Category: COVID-19 Vaccine

  • MIL-OSI USA: New study finds deer hunting can help keep chronic wasting disease in check

    Source: US Geological Survey

    BOZEMAN, Mont. — Hunting greater numbers of male deer can slow the spread of chronic wasting disease, a lethal wildlife disease, according to a new study by the U.S. Geological Survey and the Wyoming Game and Fish Department.

    Chronic wasting disease is caused by a misfolded protein called a prion, and infection leads to neurological problems, starvation, and eventually, death. The disease affects animals in the deer family, including deer, elk and moose. Chronic wasting disease is 100% lethal and highly contagious. It has rapidly spread across the U.S. since it was first discovered in the 1960s. It is now found in at least six countries, four Canadian provinces and 35 U.S. states.

    Distribution of Chronic Wasting Disease in North America, updated January 23, 2025. Chronic wasting disease has been detected in free-ranging cervids in 36 U.S. states and four Canadian provinces and in captive cervid facilities in 22 states and three provinces.

    Chronic wasting disease outbreaks are a serious concern for wildlife managers because members of the deer family are economically, culturally and ecologically important. The disease has been implicated in declines of deer and elk in several states, including in Wyoming mule deer herds where the number of animals infected can exceed 50%. The disease spreads easily through the environment from infected deer droppings, urine and saliva, and there are no vaccines or treatments, making it difficult to control. One potential tool is hunting, which might reduce the number of infected animals within a population and slow down the spread of the disease. Many states are now working to increase hunting levels in an effort to slow the spread of disease. However, hunting-based strategies are not always effective and can be controversial. Despite the interest in this management tool, there is still little real-world evidence of its effectiveness.

    The study’s authors examined chronic wasting disease trends in 10 different mule deer herds across central and eastern Wyoming, which varied in hunting pressure. They analyzed 20 years of data gathered by Wyoming Game and Fish Department to understand whether increasing hunting pressure was effective at controlling the disease.

    “We found that harvesting a high proportion of the adult males in the herd – around 40% every year for 20 years, is expected to keep chronic wasting disease infections at low numbers,” said Wynne Moss, lead author and USGS scientist. If this high level of hunting pressure is applied consistently (over 20 years), less than 5% of the males on average are expected to be infected. On the other hand, a lower level of hunting pressure, such as 20% of adult males harvested per year, would result in a much higher prevalence of around 30% infected.

    Mule deer buck in southwest Wyoming. (Photo: Tom Koerner/USFWS)

    The study also showed that harvesting a high number of males over a shorter period – 3 years in a row — still slowed the rate of disease spread within a population but was not as effective as harvesting high numbers over a multiple decades.

    “Our results suggest that the use of hunting is a promising, scientifically supported way to manage chronic wasting disease; however, it is important to note that this approach is more likely to slow the disease down than eradicate it,” said Paul Cross, co-author on the study and USGS scientist. “This study provides important evidence about the effects of hunting on wildlife disease management for deer.”

    The paper was published January 21 in Ecological Applications.

    Learn more about chronic wasting disease.

    # # # 

    The USGS provides science for a changing world. Learn more at www.usgs.gov or follow us on Facebook @USGeologicalSurvey, YouTube @USGS, Instagram @USGS, or X (formerly Twitter) at @USGS.

    MIL OSI USA News

  • MIL-OSI USA: Durbin: RFK Jr. Is Dangerously Unqualified To Serve As HHS Secretary

    US Senate News:

    Source: United States Senator for Illinois Dick Durbin
    January 27, 2025
    In a speech on the Senate floor, Durbin warns that Robert F. Kennedy Jr.’s dangerous and irresponsible views could jeopardize children’s health
    WASHINGTON – In a speech on the Senate floor, U.S. Senate Democratic Whip Dick Durbin (D-IL) today spoke out against the nomination of Robert F. Kennedy Jr., to lead the U.S. Department of Health and Human Services (HHS), citing the nominee’s false and irresponsible views on vaccines.  In his remarks, Durbin pointed to specific examples of Kennedy spreading lies about vaccines, fluoride, and other measures with proven scientific history of safety and improving health.
    “Every day HHS makes life or death decisions. That [department] oversees the Food and Drug Administration to make sure that what we eat is safe, to make sure the drugs that are sold to us are effective and safe as well. The National Institutes of Health, the premier medical research agency in the world, with $48 billion spent each year to find cures, to find new drugs, to move us toward a better America.  And the Centers for Disease Control and Prevention, to make sure that whatever is going around, as they say, doesn’t hit our families. We count on them every single day. It’s a big job, it requires responsible leadership and honesty,” Durbin began. 
    Durbin acknowledged that he has some common ground with Kennedy, specifically related to curbing pharmaceutical advertisements, which mirrors a policy laid out in Durbin’s DTC Act.
    “There may be some certain areas where we agree, such as curbing drug ads or improving the quality of food supply… I can work with him on those issues,” Durbin said.
    “But on the fundamentals… his leadership is troublesome.  Robert F. Kennedy Jr., is dangerously, dangerously unqualified and entirely irresponsible in his judgement.  He embraces quack science and cherry-picks information to fulfill his numerous conspiracy theories,” Durbin said.
    Durbin spoke to Kennedy’s record of spreading lies about the efficacy and safety of vaccines.  Durbin quoted Kennedy directly during his remarks, reiterating that Kennedy has said as recently as July 2023 that, “there’s no vaccine that is safe and effective.”
    “His decades-long crusade to spread lies about vaccines is just one example,” Durbin said.  “Contrary to scientific fact, he has also said that ‘I do believe that autism does come from vaccines.’”
    Durbin explained that Kennedy helped to publish, promote, and wrote the foreword for a book called Cause Unknown, which included faulty, unsubstantiated claims linking COVID-19 vaccines and deaths in children.  The book’s cover features the face of 12-year-old Braden Fahey, implying that COVID-19 vaccines played a role in Braden’s death.  However, Braden never received a COVID-19 vaccine—he died at football practice due to a malformed blood vessel in his brain, but the book included Braden’s photo without the knowledge or consent of his grieving parents.
    “The height of irresponsibility.  Mr. Kennedy pushes facts aside when he wants to tell us about his agenda.  The Hippocratic Oath for doctors states: first, do no harm.  But I am fearful that if we put Robert F. Kennedy Jr., in charge of our nation’s health, innocent children will die,” Durbin continued.
    “It’s no secret what he would do.  Mr. Kennedy himself petitioned the FDA to rescind authorization of all COVID vaccines in 2021.  And a key associate of his has petitioned to remove the polio vaccine,” Durbin said.
    “In 1952, polio paralyzed more than 21,000 Americans and killed more than 3,000.  But thanks to researcher Jonas Salk, a vaccine was discovered and studied among 1.3 million children… It was proven safe,” Durbin said.
    As Durbin points out, Kennedy has travelled internationally to spread doubt and falsehoods about the safety and efficacy of the measles vaccine.
    “Robert F. Kennedy Jr., has spread conspiracy theories to discourage uptake of the measles vaccine, for example – including travelling to Samoa to spread lies about its safety, fueling an outbreak that took 80 lives,” Durbin continued.  “Before the measles vaccine, 48,000 people were hospitalized each year—with thousands experiencing life-threatening brain swelling.  By 2000, measles was declared eliminated because of vaccines.”
    Durbin then spoke about Kennedy’s unsupported claims that fluoride in water is unhealthy despite clear scientific evidence proving that fluoride helps prevent cavities and dental surgery.
    “Mr. Kennedy’s dangerous, anti-science views don’t stop… He has also targeted the fluoride in drinking water.  We’ve been adding… fluoride in our drinking water for over 70 years in the United States.  We have tested it every way you can imagine, as we should, to make sure that it is safe for all of us to drink,” Durbin said.
    “This man is not a scientist… He has no special knowledge or authority when it comes to these issues and sadly, [he] buys into a myriad of conspiracy theories,” Durbin said.  “God forbid we encounter another pandemic or infectious disease threat.  Do you really want this vaccine denier, Robert Kennedy Jr., at the helm?”
    Durbin concluded his floor speech by calling on his Senate colleagues to stand against Kennedy’s nomination for the sake of public health.
    “I issue a challenge to my 99 Senate colleagues: go ask your local children’s hospital if they think this nominee, Robert F. Kennedy Jr., would help or harm their work to treat sick children,” Durbin said.  “The United States Senate is better than this.  I urge my colleagues to think twice before voting for this irresponsible nominee…  This is the wrong nominee for this critical agency.”
    Video of Durbin’s remarks on the Senate floor is available here.
    Audio of Durbin’s remarks on the Senate floor is available here.
    Footage of Durbin’s remarks on the Senate floor is available here for TV Stations.
    -30-

    MIL OSI USA News

  • MIL-OSI United Kingdom: expert reaction to UKSHA announcement of a human case avian flu detected in England

    Source: United Kingdom – Executive Government & Departments

    Scientists comment on the first human case of Avian flu detected in the UK, as announced by UKHSA. 

    Dr Alastair Ward, Associate Professor of Biodiversity and Ecosystem; Programme Lead for Zoology, University of Leeds, said:

    How likely is it that the virus has or will spread human-to-human from this case?

    “Highly unlikely. The person infected with H5N1 was asymptomatic. Their contacts have been traced and all have tested negative. Very specific genetic changes are required for avian influenzas to become transmissible among humans, and these changes are not present in the viruses isolated in this case.

    What could be done to prevent future cases of H5N1?

    “Adherence to biosecurity best practice, including the use of PPE and disinfection when handing poultry or material that may have been contaminated by them, may limit transmission of H5N1 from infected poultry to humans. Reporting of symptoms observed within a poultry flock to the Animal and Plant Health Agency, and subsequent statutory testing and control measures are critical for preventing further spread among birds, as they have been in this case.

    How worried should we be about this? How does the risk of contracting bird flu differ between people working in close contact with birds versus the general public?

    “The UKHSA and APHA have avian influenzas under ongoing surveillance. We know what the genetic changes are that make the viruses more likely to jump to humans and to transmit between humans, and they have not been detected in the UK. Risks to the general public likely remain very low. Risks to people who work in close contact with birds, particularly ducks, geese, swans, chickens and turkeys are greater, but can be reduced by implementing biosecurity best-practice, including use of PPE and disinfection when making contact with birds or material that has been contaminated by them.

    Any other information should readers know about the situation?

    “This was an isolated case involving a man in his early 80s and who kept a large flock of Muscovy ducks in a domestic setting. The man has isolated since his diagnosis and has been administered a course of antiviral medication as a precautionary measure. His contacts have been traced and tested negative. 19 of the 20 ducks tested were positive for H5N1 and so the flock was culled. These statutory measures seem to have been successful in preventing further spread among birds and to humans.”

    Prof Andrew Preston from the Milner Centre of Evolution, and Department of Life Sciences at the University of Bath, said:

    “This announcement will rightly provoke concern. The evolution of an influenza virus derived from a high pathogenicity avian influenza clone to one that is adapted to human-to-human spread is one of the most feared infectious disease threats we face. Thankfully, this is yet to happen during the current, prolonged H5N1 outbreak. This case appears to result from high levels of exposure of the individual to the virus due to their workplace contact with infected birds, a known risk factor for contracting the virus. The swift response that include tracing contacts of the individual and their monitoring and prophylactic treatment, is key to minimising any small chance of virus being passed from human to another human host.

    “However, this case highlights the continued threat posed by these avian viruses. The mixing of infected birds and other species is the major risk factor for adaptation of the virus to new host species and high vigilance for instances of this is essential to containing any possible onward transmission.”

    Professor Wendy Barclay, Regius Professor of Infectious Disease at Imperial College London, said:

    “Since the number of cases of H5N1 in poultry premises has increased again this winter, this is not unexpected. 

    “It’s important to remember that bird flu does not transmit readily between people without several simultaneous adaptive mutations in different genes. 

    “Genetic sequencing would confirm if this has happened, but with just one individual case, it is highly unlikely.”

    Declared interests

    Dr Alastair Ward I am a member of the FluMAP and Flu:TrailMAP consortia: multi-disciplinary groups of scientists funded by UKRI and Defra to better understand the ongoing H5N1 panzootic and how to better control it.

    Prof Andrew Preston I have received research funding from several companies that make vaccines, but not for any work related to influenza.

    For all other experts, no reply to our request for DOIs was received. 

    MIL OSI United Kingdom

  • MIL-OSI: BexBack Unveils Double Deposit Bonus, $50 Welcome Bonus, and 100x Leverage Crypto Trading with No KYC

    Source: GlobeNewswire (MIL-OSI)

    SINGAPORE, Jan. 27, 2025 (GLOBE NEWSWIRE) — As Bitcoin hovers around the $100,000 mark, analysts predict prolonged market volatility, making cryptocurrency derivatives trading the preferred choice for traders seeking to profit from both upward and downward trends. To empower traders and maximize their potential, BexBack Exchange has introduced an exclusive package featuring a 100% deposit bonus, a $50 welcome bonus for new users, and 100x leverage for cryptocurrency trading—all with a No KYC policy, ensuring privacy and seamless trading.

    How Does 100x Leverage Work?

    100x leverage enables traders to control larger positions with minimal capital investment. For example:

    • Suppose Bitcoin is priced at $100,000, and you open a long contract with 1 BTC. Using 100x leverage, you control a position worth 100 BTC.
    • If the price rises to $105,000, your profit will be:
      (105,000−100,000)×100BTC÷100,000=5BTC That’s a 500% return on your initial investment.

    With BexBack’s 100% deposit bonus, your trading power doubles, giving you the ability to amplify profits even further.

    How the 100% Deposit Bonus Works

    BexBack’s deposit bonus is designed to boost your trading potential. While it cannot be withdrawn directly, the bonus:

    1. Increases Margin Capacity – Use the bonus to open larger positions and enhance your profit potential.
    2. Provides Risk Protection – During significant market fluctuations, the bonus serves as extra margin, reducing liquidation risks.

    For example, depositing 1 BTC unlocks an additional 1 BTC in bonus funds, doubling your margin.

    Why Choose BexBack?

    • No KYC Required: Trade with just an email address—simple and private.
    • 100% Deposit Bonus: Double your trading funds instantly.
    • $50 Welcome Bonus: Earn $50 after completing your first trade.
    • High Leverage: Up to 100x leverage to maximize capital efficiency.
    • Demo Account: Practice risk-free with 10 BTC in virtual funds.
    • Transparent Fees: No slippage, no spreads, and clear fee structures.
    • 24/7 Global Support: Dedicated multilingual customer service anytime, anywhere.
    • Affiliate Rewards: Earn up to 50% commission with no limits on duration or earnings.

    About BexBack

    BexBack is a premier cryptocurrency derivatives platform offering 100x leverage on BTC, ETH, ADA, SOL, and XRP futures contracts. Headquartered in Singapore with offices in Hong Kong, Japan, the United States, the United Kingdom, and Argentina, BexBack operates under a US MSB (Money Services Business) license. The platform is trusted by over 200,000 traders worldwide, including users in the US, Canada, and Europe.

    Don’t Miss Out—Start Trading Today!

    If you’re looking to capitalize on Bitcoin’s historic price levels and market volatility, BexBack is the platform for you. With 100x leverage, unbeatable bonuses, and a focus on privacy, BexBack sets you up for success in the dynamic world of cryptocurrency trading.

    Sign up now to claim your exclusive bonuses and start building your crypto portfolio.

    Website: www.bexback.com

    Contact: business@bexback.com

    Contact:
    Amanda
    business@bexback.com

    Disclaimer: This content is provided by BexBack. The statements, views and opinions expressed in this column are solely those of the content provider. The information provided in this press release is not a solicitation for investment, nor is it intended as investment advice, financial advice, or trading advice. It is strongly recommended you practice due diligence, including consultation with a professional financial advisor, before investing in or trading cryptocurrency and securities. Please conduct your own research and invest at your own risk.

    Photos accompanying this announcement are available at:

    https://www.globenewswire.com/NewsRoom/AttachmentNg/ed72ce34-c448-429b-baf5-afdbccee1640

    https://www.globenewswire.com/NewsRoom/AttachmentNg/b63bbbd5-050a-4972-9308-fa38c4b98ca8

    https://www.globenewswire.com/NewsRoom/AttachmentNg/8fe9b4af-bef7-450b-8933-9d7096274920

    https://www.globenewswire.com/NewsRoom/AttachmentNg/a1ccb133-7ea0-4960-a4b2-f127cce10ea8

    https://www.globenewswire.com/NewsRoom/AttachmentNg/9778b6a3-46d2-49b8-a574-adb73a41cd4f

    The MIL Network

  • MIL-OSI United Kingdom: Human case of avian flu detected in England

    Source: United Kingdom – Executive Government & Departments

    UKHSA confirms rare case of bird flu (H5N1) in the West Midlands region.

    UKHSA has confirmed a case of influenza A(H5N1) in a person in the West Midlands region. Bird-to-human transmission of avian influenza is rare and has previously occurred a small number of times in the UK.

    The person acquired the infection on a farm, where they had close and prolonged contact with a large number of infected birds. The risk to the wider public continues to be very low.

    The individual is currently well and was admitted to a High Consequence Infectious Disease (HCID) unit.

    The birds were infected with the DI.2 genotype, one of the viruses known to be circulating in birds in the UK this season. This is different to strains circulating among mammals and birds in the US.

    Although there has been no demonstrated human-to-human transmission despite extensive recent surveillance of influenza A(H5N1), UKHSA has been tracing all individuals who have been in contact with the confirmed case of avian influenza. Those at highest risk of exposure have been offered antiviral treatment. This is done to reduce the chance that any virus they have been exposed to will be able to cause infection.

    The case was detected after the Animal and Plant Health Agency (APHA) identified an outbreak of avian influenza(H5N1) in a flock of birds. UKHSA carried out routine monitoring on people who had been in close contact with the infected birds.

    Professor Susan Hopkins, Chief Medical Adviser at UKHSA, said:

    The risk of avian flu to the general public remains very low despite this confirmed case. We have robust systems in place to detect cases early and take necessary action, as we know that spillover infections from birds to humans may occur.  

    Currently there is no evidence of onwards transmission from this case.

    People are reminded not to touch sick or dead birds and it’s important that they follow Defra advice about reporting any suspected avian influenza cases.

    UK Chief Veterinary Officer Christine Middlemiss said:

    While avian influenza is highly contagious in birds, this is a very rare event and is very specific to the circumstances on this premises.

    We took swift action to limit the spread of the disease at the site in question, all infected birds are being humanely culled, and cleansing and disinfection of the premises will be undertaken all to strict biosecure standards. This is a reminder that stringent biosecurity is essential when keeping animals.

    We are seeing a growing number of avian flu cases in birds on both commercial farms and in backyard flocks across the country. Implementing scrupulous biosecurity measures will help protect the health and welfare of your birds from the threat of avian influenza and other diseases.

    Andrew Gwynne, Minister for Public Health and Prevention, said:

    The safety of the public is paramount, and we are monitoring this situation closely.

    The risk of wider or onward transmission is very low, however the UK remains prepared and ready to respond to any current and future health threats.

    We recently added the H5 vaccine, which protects against avian influenza, to our stockpile as part of our preparedness plans.

    UKHSA will publish further details about the confirmed human case in due course.

    Updates to this page

    Published 27 January 2025

    MIL OSI United Kingdom

  • MIL-OSI Global: Norovirus, aka the winter vomiting bug, is on the rise – an infectious disease expert explains the best ways to stay safe

    Source: The Conversation – USA – By William Schaffner, Professor of preventive medicine, health policy, infectious diseses, Vanderbilt University

    Norovirus is accompanied by abdominal pain, diarrhea and explosive vomiting. Alla Bielikova/Moment via Getty Images

    The highly contagious norovirus – popularly known as “stomach flu” or the “winter vomiting bug” – is now surging through the U.S.. The number of outbreaks is up significantly over previous years, possibly due in part to a new strain of the virus. Outbreaks can occur after direct contact with someone who is infected. Food and household surfaces can also become contaminated.

    William Schaffner, a professor of preventive medicine and infectious diseases at the Vanderbilt University School of Medicine, discusses the symptoms of norovirus, how best to treat it, and the populations most vulnerable to this illness.

    Dr. William Schaffner discusses the norovirus.

    The Conversation has collaborated with SciLine to bring you highlights from the discussion that have been edited for brevity and clarity.

    What are the symptoms of a norovirus infection?

    William Schaffner: Norovirus is an intestinal virus that can make you very, very sick. It is indelicately called winter vomiting disease, and it begins suddenly, often with an explosive vomit that then repeats itself.

    Norovirus can cause abdominal pain and diarrhea at the same time, along with a fever. It will probably make you feel miserable for two or three days – but then everybody pretty much recovers.

    How should norovirus be treated?

    William Schaffner: The major problem norovirus causes is dehydration from all that vomiting and diarrhea. So you have to stay hydrated. Do this with little sips of clear liquids, because if you take too much, it’ll come right back up. Sports drinks are very good.

    Most people who get into trouble are either very young or older and more frail. They may have to go to the hospital to get rehydrated with an IV. When the occasional death occurs due to this dehydrating infection, it’s in those vulnerable populations.

    Why does norovirus tend to surge during the winter?

    William Schaffner: You can get it any time of the year, but there is a seasonal increase in the winter for reasons that scientists are not quite sure of. But people spend a lot of time indoors with each other in wintertime, so that makes it easier for the virus to get from one place to another. All that travel over the holidays, as well as family gatherings and parties, can spread the virus.

    How can people protect themselves from the norovirus?

    William Schaffner: The most important thing is good hand hygiene. Washing with soap and water works the best. Those hand hygiene gels and wipes – the hand sanitizers – that people tend to use aren’t as effective against norovirus, so just wash frequently with good old soap and water. And then, of course, avoid people who are sick.

    Also, remember that the virus can survive on environmental surfaces, like counters, doorknobs and tables. You don’t want to pick up those viruses on your fingers. If you get a little bit of virus on your fingertips and then touch your lips, you can get an infection because it just takes a small dose of the virus to make you sick.

    Who’s particularly vulnerable to norovirus?

    William Schaffner: The people who are more susceptible to catching it are those living in semi-enclosed or enclosed populations. For example, people in nursing homes, schools and prisons – essentially any circumstance where people are together for a long period of time.

    Another place where the virus can spread is cruise ships, which is why norovirus is also called the cruise ship virus. When people are confined on a ship for days and days, these outbreaks can run through most of the passengers.

    Interestingly enough – and this has never been well explained – the crew is usually less affected.

    But again, the most serious illness occurs in older, frail and immune-compromised people, or in the very young, where dehydration can be more serious.

    Where’s the research on developing a norovirus vaccine?

    William Schaffner: Norovirus has presented some scientific challenges. It’s actually rather difficult to grow in the laboratory, and so that has delayed the development of a vaccine. But researchers are working on it.

    Are there other infectious diseases going around right now?

    William Schaffner: Along with norovirus, respiratory viruses are still out there: influenza, COVID-19 and respiratory syncytial virus, or RSV. They’re all perking up at the same time. It looks as though we’re having a very brisk winter viral season.

    Watch the full interview to hear more.

    SciLine is a free service based at the American Association for the Advancement of Science, a nonprofit that helps journalists include scientific evidence and experts in their news stories.

    William Schaffner receives funding from the CDC-sponsored Emerging Infections Program Collaborative Agreement.

    ref. Norovirus, aka the winter vomiting bug, is on the rise – an infectious disease expert explains the best ways to stay safe – https://theconversation.com/norovirus-aka-the-winter-vomiting-bug-is-on-the-rise-an-infectious-disease-expert-explains-the-best-ways-to-stay-safe-247667

    MIL OSI – Global Reports

  • MIL-OSI Global: Why government can’t make America ‘healthier’ by micromanaging groceries purchased with SNAP benefits

    Source: The Conversation – USA – By Benjamin Chrisinger, Assistant Professor of Community Health, Tufts University

    More than 41 million Americans use SNAP benefits to buy groceries. Brandon Bell/Getty Images

    President Donald Trump’s pick for director of the Health and Human Services Department, Robert F. Kennedy Jr., has announced a bold plan. He wants to “Make America Healthy Again.”

    Kennedy’s strategy has gotten a lot of attention for its oddities, such as his opposition to vaccine mandates and support for raw milk. But it includes some concepts that many public health experts consider sensible, such as calling for a stronger focus on chronic disease prevention and seeking more restrictions on prescription drug advertising aimed at consumers.

    But he’s also demanding a ban on junk food from the Supplemental Nutrition Assistance Program. Banning junk food from SNAP is something that has divided public health experts for years.

    As public health researchers, we’ve devoted our careers to helping reduce chronic diseases. We agree with Kennedy that a healthy diet and sound nutrition are important ways to improve the nation’s health. We also know from our own research that safety net programs, including SNAP benefits – which are still sometimes called food stamps – are staving off hunger and food insecurity for millions of Americans.

    And we’re certain that adding to the restrictions that already limit access to SNAP benefits do little to make Americans healthier.

    What is SNAP?

    Over 42.1 million Americans, about 13% of all families, receive SNAP benefits. More than 1 in 4 of the households enrolled in the program include someone who is earning at least some income.

    More than 4 in 5 families getting SNAP benefits include a child, someone over 65 or someone with a disability. These benefits are distributed on a monthly basis through an electronic benefits transfer card that looks and works like a credit or debit card and can be used at supermarkets and other approved retailers. The federal government has spent more than US$110 billion annually on this program in recent years.

    Benefits help get food on the table but typically don’t cover everything a family needs to eat. The average monthly benefit is $195 per person.

    Americans who earn less than 130% of the poverty line are eligible for SNAP. In the 2025 fiscal year, a family of three can’t make more than $2,152 a month in net income or have assets of more than $4,500 if a household includes someone over 60, and $3,000 if it doesn’t.

    Adults without children or disabilities can’t get these benefits for more than three months every three years unless they meet the program’s work requirements by being employed or spending at least 20 hours weekly in a training program. People who are on strike and foreigners living in the U.S. without authorization are ineligible. People with prior drug-related felony convictions are federally banned from SNAP for life, but states can waive this rule. This program is federally funded but administered by the states, which have some leeway in determining eligibility.

    People enrolled in SNAP already face some restrictions on what they can buy with their benefits. They can’t use SNAP to purchase premade or restaurant meals, alcohol, tobacco, or things such as diapers, vitamins and toilet paper.

    Why restrict SNAP?

    Since SNAP is administered by the U.S. Department of Agriculture, Kennedy would have very little power to change SNAP’s rules should the Senate approve his nomination following the controversial politician’s upcoming confirmation hearing on Jan. 29, 2025.

    Still, we’re concerned that his support for new restrictions could help sway the authorities who would be responsible for such a policy change.

    Proposals to ban particular foods from SNAP have been floated many times by state legislators and members of Congress over the years.

    These bills have generally been designed to exclude supposedly luxury items, such as steak and seafood, or aimed at barring purchases from a different supermarket aisle: candy, soda and other junk foods.

    States can’t make this kind of modification without the USDA’s authorization. And so far, the USDA has rebuffed calls for it to allow such measures. Even without the agency’s support, Congress can make changes to these policies in the Farm Bill, which could in the future force the USDA to allow these restrictions in states that ask for them.

    The Trump administration, including Kennedy, has signaled its interest in these kinds of restrictions.

    Why SNAP restrictions won’t make America healthier

    While improving the American diet is a worthy goal, research that we and other scholars have done makes it clear that adding new restrictions to SNAP will do little to help us become a healthier nation.

    First, many studies have found that nearly all Americans could eat healthier.

    The rich and the poor alike consume unhealthy food in the U.S.

    Studies show that while lower-income Americans often spend more of their food budget on unhealthy stuff than more affluent people do, families in the middle and at the top of the income ladder still purchase lots of junk food.

    Unsurprisingly, those purchases reflect what we’re eating: Americans at all income levels have diets that don’t satisfy federal dietary guidelines. Spotlighting the poor food choices of SNAP participants would be a distraction from these facts and would risk further stigmatizing a successful anti-hunger program.

    Maintaining a good diet is not cheap or straightforward, especially on a low income. The poorest communities have far more inexpensive fast-food chains and dollar stores than their wealthier neighbors, as well as more ads for unhealthy products. Even when they get SNAP benefits, many Americans still struggle to make ends meet, and studies show how this negatively affects the quality of their diets.

    Another reason SNAP restrictions wouldn’t make America healthier is that diet is just one of many contributors to chronic diseases. Your level of physical activity, exposure to pollution, stress and genetics, among other things, shape your risk of getting heart disease, diabetes or other chronic diseases.

    Flexible but don’t cover all needs

    SNAP benefits are fairly flexible, covering just about anything people might want to eat, even if they have dietary restrictions due to their culture or health conditions. The program helps Americans afford most of their basic necessities, although it fails to pay for all the groceries most people who rely on the program need to buy in the course of a month.

    SNAP’s main function is preventing the worst effects of hunger and food insecurity for the more than 41 million people relying on it.

    There are other ways for the government to help make Americans healthier besides the imposition of stigmatizing restrictions on SNAP. For example, it can create matching programs for SNAP dollars spent on fruits and vegetables, which would give retailers incentives to offer more produce and make it easier for people who get SNAP benefits to buy more healthy food. The USDA has begun to support this kind of effort in several states.

    Benjamin Chrisinger receives funding from The Research Innovation and Development Grants in Economics (RIDGE) Partnership.

    Danielle Krobath does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

    ref. Why government can’t make America ‘healthier’ by micromanaging groceries purchased with SNAP benefits – https://theconversation.com/why-government-cant-make-america-healthier-by-micromanaging-groceries-purchased-with-snap-benefits-246462

    MIL OSI – Global Reports

  • MIL-OSI United Kingdom: Improving Access to Scotland’s NHS: We Can Renew Scotland’s NHS and Help Our Nation Thrive

    Source: Scottish National Party

    Like all of us, the National Health Service is personal for me – I see first-hand all that it does, and has done, for my own family.

    In the last years of my beloved Mother’s life, I saw such care and attentiveness in the community and in hospital care.

    My wife would not have the capacity and capability she has in dealing with MS, had it not been for the outstanding care and insight of the National Health Service alongside, might I say, her absolutely personal determination to stay strong.

    I would not have had such joy in my life at the birth of my three children without the National Health Service.

    It is personal for all of us.

    That is why we care about it so much.

    That is why we want to see it thriving once again.

    We all know the tremendous pressures our NHS has been under in recent years.

    We see a service still reeling from the strain of a global pandemic – a pandemic that revealed the NHS’s many strengths but also exposed its underlying weaknesses.

    Weaknesses made worse by a decade and a half of austerity, and by the body blow of inflation that has meant – as we know from our own family finances – the available money delivers less.

    It is a service still beset by backlogs and delayed discharges, and struggling to meet the increasing needs of an ageing population.

    The challenges are great, of that I have no doubt. But I know also that our NHS is fundamentally resilient, fundamentally robust.

    I witnessed both these realities earlier this month when I spent a Saturday evening visiting the emergency department at the Royal Infirmary of Edinburgh.

    In the midst of both winter pressures and a particularly challenging flu season, I saw patients who waited too long to be seen, but also staff who went above and beyond.

    I saw an NHS that in the face of the storm kept on standing, kept on delivering.

    There are some who oppose the NHS model, who believe that the answer to our health challenges is a privatisation of care. They want us to believe that the health service is beyond saving, that it is on the point of collapse.

    But that is simply not true.

    There are challenges.

    Some services are struggling.

    Periods of real crisis as we have seen in recent weeks as flu cases spiked.

    The impact of these issues on too many patients is real.

    But, as I will set out today, there is nothing wrong with the National Health Service that can’t be fixed by what is right with the National Health Service.

    What is right with the National Health Service includes the thousands of health and care staff who are doing phenomenal things under enormous pressure.

    People who, time and again, display resilience, selflessness and grit, who truly go above and beyond.

    It includes innovations, such as the Rapid Cancer Diagnostic Service, a new pathway that delivers significant reductions in the time from referral to diagnosis, opening the door also to faster treatment.

    It includes national public health initiatives like the HPV vaccination programme, which has resulted in no cases of cervical cancer in young women who have been fully vaccinated.

    A remarkable, utterly remarkable, life-saving achievement.

    And it includes cutting-edge research, multiple projects, looking into the ways AI can transform diagnosis and treatment in the years to come.

    The foundations on which we will build NHS recovery and renewal are strong.

    Under this Government, the NHS will always remain in the hands of the public and free at the point of use. That is non-negotiable.

    The question then becomes how do we do better?

    How do we ensure our health service is not just the best in these isles but the best it can possibly be?

    The answer to that question is not a simple one. There is no ‘magic bullet’.

    Rather, it involves progress across multiple fronts, a balancing of sometimes competing demands and interests.

    It will require choices and action by central government, yes, but that must be delivered in partnership with others – local government, the third sector, patient groups, and health and social care workers at all levels.

    It must deliver reform that is fundamentally patient-centred but do so through a health and social care system that becomes an ever more interconnected whole.

    I have said before that my approach as First Minister is to seek the right solutions, not merely the quick ones.

    I favour consensus building and collaboration over diktats from on high. For the future success of our NHS this is not only the right approach, but also the necessary approach.

    We will only succeed on this path of reform and renewal if we walk it together.

    That is why the Cabinet Secretary for Health and I meet regularly with staff in all parts of the National Health Service.

    It is why we have been engaging with health boards, local government, Health and Social Care Partnerships, the Scottish Ambulance Service, Public Health Scotland, and NHS 24.

    We have listened carefully, also, to patients and their families, to all those who depend on the NHS for lifesaving, life-enhancing care.

    We have been told all that is going well and all that must be better.

    We have heard the advice from those with direct, frontline experience. And that has helped us develop a clear understanding of where the challenges are, and what changes are needed.

    It is this kind of open, collaborative approach, with a focus on solutions, on the right answers over the easy ones, that has led to the actions I am setting out today.

    It is a set of actions with clear outcomes – tangible improvements that we can and will deliver.

    Tangible improvements to make people’s experience of the NHS in Scotland better than it is today.

    Actions made possible by the record funding we are delivering to the NHS frontline.

    Actions that will address the immediate issues in our health service – those problems of access that I know cause so much frustration, and indeed for some, unnecessary pain.

    Actions that set out a new course so we can safeguard the NHS for the long-term.

    Over the coming weeks, the Government will set out for Parliament what the different elements of our approach will mean in practice.

    And we will be reminding Members of Parliament as we do that, that the delivery of this stronger NHS depends on the safe progress of the draft Budget currently being considered by Parliament.

    The actions we will take to deliver a more accessible, more person-centred NHS have three clear purposes:

    First, to reduce the immediate pressures across the NHS.

    Second, to shift the balance of care from acute services to the community.

    Third, to use innovation – digital and technological – to improve access to care.

    Together, these will address the problems that right now, every day weigh down our National Health Service.

    They will begin to deliver the long-term, systemic improvement that is needed to ensure our health service is sustainable for the future.

    And they will make it easier for people across Scotland to live healthier lives, helping us to build a future in which health is practiced in homes and communities as much as it is practiced in surgeries and hospitals.

    So let’s talk first about those immediate problems, the crises facing too many parts of our National Health Service.

    The first and most important thing on many people’s minds is how long it can take to access services.

    Delays in access, with waiting times that are too long, and delays in discharge, because appropriate at home or in community care is not available.

    The two, of course, are fundamentally connected.

    Last year, I referred to delayed discharge as the canary in the coal mine of our National Health Service. I think of waiting times in much the same way.

    Both these delays tell us that the flow of people through the health system is not happening as it should.

    Put more simply, people are not getting the right care in the right place, at the right time.

    That is not acceptable to me.

    It is not acceptable to my Government, because it can lead to people getting sicker as they wait, and it can mean they can take longer to recover.

    It adds substantially to the stress they and their loved ones experience.

    It creates greater strain across the system, leading to more delays elsewhere, poorer outcomes for others and still further stress on services.

    It is the very definition of a vicious circle, and it has to come to an end.

    So, today, we commit to a substantial increase in capacity in order to significantly reduce people’s waits.

    The changes we propose – including an enhanced regional delivery model, alongside increased levels of activity in our National Treatment Centres – will deliver over 150,000 extra appointments and procedures – in hospitals, in communities – in the coming year.

    That includes 10,000 extra procedures through smarter working in the National Treatment Centres.

    Other sites – including Gartnavel, Inverclyde, Stracathro, Perth Royal Infirmary and Queen Margaret Hospital – will deliver 9,500 extra cataract procedures.

    As well as 2,500 extra orthopaedic appointments and procedures – operations such as hip or knee replacements.

    In this way, we will create centres of excellence, places of expertise and specialisation, where we will be better placed to capitalise on the technological innovation and the potential of AI.

    And we will cut our waiting lists.

    Cancer referrals, gynaecology, ophthalmology, orthopaedics, and radiology – all benefiting from this new investment.

    Centres able to deliver more care, more quickly and more efficiently than traditional, smaller, more fragmented facilities – with transport support provided for those who need it.

    And, to ensure that they do, we will put in place clear milestones and targets for those specialities that add the most to our waiting lists.

    Our second focus will see more and better care delivered in the community.

    I spoke earlier about the importance of people receiving the right care at the right time, in the right setting.

    That right setting will always be the least intensive setting appropriate to the person’s needs.

    Sometimes that appropriate setting is in hospital. More often, it is not.

    So to strengthen and renew our NHS, we will shift more care into communities and into homes.

    As much as possible, people who do not need to be in hospital will not go to hospital, protecting those acute services for those who absolutely need them.

    This new approach will mean changing the way we deliver acute services.

    By this summer, we will have specialised staff in frailty teams, at the front door of every A&E department in Scotland.

    This will mean that frail patients, often older patients with complex needs, will bypass our busy A&Es, in order to receive the specialist care and support they need, whether in hospital or back at home.

    It will mean better care for these most vulnerable patients while reducing the pressure on our A&Es.

    Our actions will also improve the NHS’s capacity to treat people at home.

    Our Hospital at Home initiative, which allows hospital-levels of care in a person’s home, will be expanded to at least 2,000 beds by the end of 2026.

    Without the need for any new bricks and mortar, the effective capacity of every single hospital in Scotland will be expanded.

    Taken together, it is action that will ease acute pressures, reduce delays, cost less to our NHS, and most importantly, help people get better more quickly, more comfortably.

    Quality care for thousands of Scots delivered not simply close to home, but at home.

    Of course, we cannot simply shift services out of acute settings. We also need to build capacity in our primary care and community health settings.

    With this in mind, the Government has been listening carefully to the views of Scotland’s GPs.

    They have described the multiple contributions general practice can make as we shift to more community-focused care. They have argued that GPs must be given the resources they need to fulfil that role.

    We have listened, and we have been persuaded.

    As a result, our plan will ensure that a greater proportion of new NHS funding goes to primary and community care.

    GPs and services in the community will have the resources they need to play a greater role in our health system.

    This increased investment will result in GP services that are easier for people to access.

    That is important in terms of people’s confidence in the health service – indeed, difficulties making GP appointments top the list of issues that people often raise with me.

    But equally, it will make it more likely that health issues are picked up quickly and dealt with earlier.

    For there is no better way to deal with illness than to prevent it.

    Addressing conditions early and intervening to prevent diseases from progressing, prevents manageable conditions from becoming serious ones.

    It is good for patients and of vital importance for the future sustainability of our National Health Service.

    That is why our plan also includes £10.5 million to build GP capacity to intervene earlier and prevent illnesses, such as cardiovascular disease.

    But this is not only an issue of money. We must also innovate and identify new ways of working.

    For example, I want to see the NHS Scotland Pharmacy First Service expand so that community pharmacies can treat a greater number of clinical conditions and prevent the need for a GP visit in the first place.

    The third part of our approach is innovation to improve access to, and delivery of, care.

    Better use of data will ensure that more operating theatres are working at maximum capacity, with best practice approaches, approaches shown to increase productivity by 20%, rolled out across the country.

    Using existing capacity, more operations will be delivered – enabling us to also deliver shorter waiting times.

    The latest innovations in genetic testing will be harnessed to enable better targeting of medications in cases ranging from recent stroke patients to new-born infants with bacterial infections.

    Smarter care, better care.

    Building on the already successful model of digital support for mental health – a service that saw 74,000 referrals in 2023-24 – we will offer support in additional areas including dermatology and the management of long-term conditions.

    This type of care, because it is not dependent on physical attendance, at a specific time, in a specific place, is more flexible.

    It means care can be made to fit better into the lives of those who use the services.

    Again, smarter care, and better care.

    And, as a much-needed addition to improve patients’ interaction with the NHS, there will be a Scottish health and social care app.

    This ‘Digital Front Door’ will begin rollout from the end of this year, starting in Lanarkshire, and, over time, it will become an ever more central, ever more important access and management point for care in Scotland.

    This is the third in a series of speeches I have delivered in recent weeks.

    In each I have spoken about the importance of identifying clear goals, clear direction to national policy.

    If we have a clear sense of the direction we wish to travel, the levels of success we wish to achieve, and if we can unite behind these goals, then genuine progress becomes all the more possible.

    Protecting, strengthening, renewing our National Health Service – that is a goal I think we can all get behind.

    MIL OSI United Kingdom

  • MIL-OSI Asia-Pac: Severe case of influenza A infection in unvaccinated infant reported

    Source: Hong Kong Government special administrative region

    Severe case of influenza A infection in unvaccinated infant reported
    Severe case of influenza A infection in unvaccinated infant reported
    ********************************************************************

         The Centre for Health Protection (CHP) of the Department of Health today (January 27) received a report of a case of severe paediatric influenza A infection in a baby girl who had not yet received the seasonal influenza vaccination (SIV). She is still hospitalised and in serious condition. The CHP urged the public who have not yet received the SIV to act immediately to minimise the risk of serious complications and death after infection.                “The 10 month-old girl with good past health developed a fever, cough and seizure since January 23. She attended the Accident and Emergency Department of United Christian Hospital on the same day and was admitted to the paediatric intensive care unit immediately. Her nasopharyngeal swab specimen tested positive for the influenza A (H1) virus upon laboratory testing. The clinical diagnosis was influenza A infection complicated with encephalitis,” a spokesman for the CHP said.     The girl had no travel history during the incubation period. One of her household contacts had upper respiratory symptoms prior to her disease onset. An initial investigation revealed that she did not receive 2024/25 SIV. The CHP reiterated its call to the parents to bring their children to receive an SIV as soon as possible.                “Including the above-mentioned baby girl, the CHP has recorded five cases of severe influenza virus infection in children since the start of this influenza season in early January, four of whom were unvaccinated. Influenza vaccination has been scientifically proven to be one of the most effective ways to prevent seasonal influenza and its complications, while significantly reducing the risk of hospitalisation and death from seasonal influenza. All persons aged 6 months and above (except those with known contraindications) who have not yet received SIV should act immediately, particularly the elderly and children who have a higher risk of becoming infected with influenza and developing complications,” the spokesman said.                The spokesman reminded the public that Hong Kong has entered the influenza season. The seasonal influenza activity is expected to increase further while the activity of other respiratory infectious diseases may also increase. To protect their health and that of their family members, the public should not only receive the SIV, but also maintain good personal and environmental hygiene, and take the following measures to prevent contacting influenza and other respiratory illnesses: 

    Patients can wear surgical masks to prevent transmission of respiratory viruses. Therefore, it is essential for persons who are symptomatic (even if having mild symptoms) to wear a surgical mask;
    High-risk persons (e.g. persons with underlying medical conditions or persons who are immunocompromised) should wear surgical masks when visiting public places. The general public should also wear a surgical mask when taking public transport or staying in crowded places. It is important to wear a mask properly, including performing hand hygiene before wearing and after removing a mask;
    Avoid touching one’s eyes, mouth and nose;
    Wash hands with liquid soap and water properly whenever possibly contaminated;
    When hands are not visibly soiled, clean them with 70 to 80 per cent alcohol-based handrub;
    Cover the mouth and nose with tissue paper when sneezing or coughing. Dispose of soiled tissue paper properly into a lidded rubbish bin, and wash hands thoroughly afterwards;
    Maintain good indoor ventilation;
    When having respiratory symptoms, wear a surgical mask, consider refraining from going to work or school, avoid going to crowded places and seek medical advice promptly; and
    Maintain a balanced diet, perform physical activity regularly, take adequate rest, do not smoke and avoid overstress.

         For the latest information, members of the public can visit the CHP’s seasonal influenza and COVID-19 & Flu Express webpages. 

     
    Ends/Monday, January 27, 2025Issued at HKT 19:27

    NNNN

    MIL OSI Asia Pacific News

  • MIL-OSI Asia-Pac: Building a Healthier Nation

    Source: Government of India

    Building a Healthier Nation

    Key Health Indicators reflect India’s Progress

    Posted On: 22 DEC 2024 6:41PM by PIB Delhi

    India’s journey toward building a healthier nation is marked by substantial progress in healthcare access, equity, and outcomes. Over the past decade, India has implemented transformative policies and initiatives that reflect a steadfast commitment to achieving Universal Health Coverage.A key milestone in this journey was the launch of the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY).

    AB-PMJAY provides health cover of Rs. 5 lakh per eligible beneficiary family per year for secondary and tertiary care hospitalizations corresponding to 1,961 treatment procedures across 27 specialties. As of December 17, 2024, AB PM-JAY has made significant strides with over 36.28 crore Ayushman Cards issued, empowering millions with health coverage.Gender-wise utilization shows that Women account for 49% of the issued Ayushman cards and almost 50% of total hospital admissions, showcasing the scheme’s role in promoting gender equity in healthcare.Additionally,AB PM-JAY has successfully empaneled 30,932 hospitals across the country.

    Parallelly, India’s digital health infrastructure has seen remarkable advancements through the Ayushman Bharat Health Account (ABHA) initiative.  ABHA Number is a hassle-free method of accessing and sharing your health records digitally. It will bridge the existing gap amongst different stakeholders of healthcare ecosystem through digital highways.The digital infrastructure supporting healthcare has also seen remarkable progress. As on 22 December 2024, over71.81 crore ABHA numbers have been generated and 46.53 crore health recordshave been linked with ABHA. In addition to this, over 3.55 Lakh health facilities have been registered on HFR and more than 5.38 lakh healthcare professionals have been registered on HPR

    Another cornerstone of India’s healthcare achievements is Mission Indradhanush, which has expanded immunization coverage under the Universal Immunization Programme. The campaign targets areas with low immunization rates to vaccinate left-out and dropped-out children and pregnant women.Mission Indradhanush includes a provision of 11 types of vaccines enhancing protection against preventable diseases.A total of 5.46 crore children and 1.32 crore pregnant women have been vaccinated in all phases of Mission Indradhanush conducted so far in the country.

    These efforts are underscored by a remarkable improvement in key health indicators, which highlight the effectiveness of targeted healthcare strategies and interventions.Maternal Mortality Ratio reduced from 103 per 100,000 live births in 2017-2019 to 97 per 100,000 live births in 2018-20. Infant Mortality Rate reduced from 32 per 1000 live births in 2018 to 28 per 1000 live births in 2020 and Total Fertility Rate is reduced from 2.2 in 2015-16 to 2.0 in 2019-21. This progress is a testament to consumer-centric policies and initiatives supported by regular monitoring to ensure efficiency and impact.

    India’s health infrastructure has witnessed transformative changes guided by visionary policies and robust implementation of initiatives like Ayushman Bharat and Mission Indradhanush. These milestones are a testament to India’s unwavering commitment to achieving Universal Health Coverage and building a healthier future for all citizens. As the country continues to strengthen its health infrastructure, the foundation is being laid for a robust, inclusive, and sustainable healthcare system that prioritizes the well-being of every individual.

    References

    RAJYA SABHA UNSTARRED QUESTION NO.2514:https://sansad.in/rs/questions/questions-and-answers

    LOK SABHA UNSTARRED QUESTION NO. 4343: https://sansad.in/ls/questions/questions-and-answers

    https://pib.gov.in/PressReleasePage.aspx?PRID=2085208

    https://pib.gov.in/PressReleasePage.aspx?PRID=2085204

    https://abdm.gov.in/

    https://dashboard.pmjay.gov.in/pmj/#/

    Click here to see in PDF:

    Santosh Kumar/Sarla Meena/ Madiha Iqbal

    (Release ID: 2087048) Visitor Counter : 47

    MIL OSI Asia Pacific News

  • MIL-OSI Asia-Pac: English rendering of PM’s address at the Indian Community Event ‘Hala Modi’ in Kuwait

    Source: Government of India (2)

    Posted On: 21 DEC 2024 9:22PM by PIB Delhi

    Bharat Mata ki—Jai!

    Bharat Mata ki—Jai!

    Bharat Mata ki—Jai!

    Namaskar!

    I arrived in Kuwait just two or two and a half hours ago. And ever since I set foot here, I have felt a unique sense of belonging and warmth all around. You all have come from different states of Bharat, but looking at all of you, it feels as if a mini Hindustan has come alive before me. Here, I see people from North, South, East, and West, speaking different languages and dialects. Yet, there is one common echo in everyone’s hearts, one resounding chant in everyone’s hearts – Bharat Mata ki Jai, Bharat Mata ki—Jai.

    Here, there is a festive atmosphere of culture. Right now, you are preparing for Christmas and New Year. Soon, Pongal will arrive. Whether it’s Makar Sankranti, Lohri, Bihu, or many such festivals, they are not far away. I extend my heartfelt wishes to all of you for Christmas, New Year, and all the festivals celebrated in every corner of the country.

    Friends,

    Today, this moment is very special for me personally. After 43 years—more than four decades—a Prime Minister of Bharat has come to Kuwait. It takes just four hours for you to travel from Bharat to Kuwait, but it took a Prime Minister four decades to make this journey. Many of you have been living in Kuwait for generations. Some of you were even born here. And every year, hundreds of Indians join your community.  You have added a touch of Indian flavour to Kuwaiti society, painted the canvas of Kuwait with the colours of Indian skills, and blended Bharat’s talent, technology, and tradition into the fabric of Kuwait.  That is why I am here today—not just to meet you, but to celebrate your achievements.

    Friends,

    A little while ago, I met Indian workers and professionals working here. These friends are involved in construction work and are contributing their hard work in many other sectors as well. Members of the Indian community, as doctors, nurses, and paramedics, are a significant strength of Kuwait’s medical infrastructure.  Those among you who are teachers are contributing to strengthening Kuwait’s next generation. Those of you who are engineers and architects are building the next generation of infrastructure in Kuwait.

    And friends,

    Whenever I speak with the leadership of Kuwait, they always praise you all immensely. The citizens of Kuwait also hold great respect for you because of your hard work, honesty, and skills.  Today, Bharat is the world leader in remittances, and a significant share of the credit for this achievement goes to all of you hardworking friends. Your contribution is deeply respected by your fellow countrymen back home.

    Friends,

    The relationship between Bharat and Kuwait is one of civilizations, of the sea, of affection, and of trade. Bharat and Kuwait are situated on opposite shores of the Arabian Sea. It is not just diplomacy that binds us, but also the connection of hearts. Our present ties are as strong as our shared history.  There was a time when pearls, dates, and magnificent breeds of horses from Kuwait were sent to Bharat, while many goods from Bharat made their way here. Indian rice, tea, spices, fabrics, and wood were regularly brought to Kuwait. The teakwood from Bharat was used to build ships on which Kuwaiti sailors undertook long voyages.  The pearls of Kuwait have been as precious as diamonds to Bharat. Today, Indian jewellery is renowned worldwide, and Kuwaiti pearls have contributed to that legacy.  In Gujarat, we often hear stories from our elders about how, in past centuries, there was constant travel and trade between Kuwait and Bharat. Particularly in the 19th century, Kuwaiti traders started coming to Surat. At that time, Surat was an international market for Kuwaiti pearls. Ports like Surat, Porbandar, and Veraval in Gujarat stand as witnesses to these historic connections.

    Kuwaiti traders have even published numerous books in the Gujarati language. After Gujarat, Kuwaiti traders established a distinct presence in Mumbai and other markets as well. One notable example is the renowned Kuwaiti merchant Abdul Latif Al Abdul Razzak, whose book ‘How to Calculate Pearl Weight’ was published in Mumbai. Many Kuwaiti traders opened offices in Mumbai, Kolkata, Porbandar, Veraval, and Goa for their export and import businesses. Even today, many Kuwaiti families reside in Mumbai’s Mohammad Ali Street.  It might surprise many to learn that 60-65 years ago, the Indian rupee was used in Kuwait just as it was in Bharat. Back then, if someone purchased something from a shop in Kuwait, Indian rupees were accepted as currency. Terms like “Rupiya,” “Paisa,” and “Aana,” which were part of Indian currency vocabulary, were very familiar to the people of Kuwait.

    Friends,

    Bharat was one of the first countries in the world to recognize Kuwait after its independence. That is why visiting a country and society with which we share so many memories and such deep connections in both our past and present is truly memorable for me.  I am deeply grateful to the people of Kuwait and its government. I would like to especially thank His Highness The Amir for his kind invitation.

    Friends,

    The bond forged through culture and commerce in the past is now reaching new heights in this new century. Today, Kuwait is a very significant energy and trade partner for Bharat, and Bharat is also a major investment destination for Kuwaiti companies. I vividly recall a saying mentioned by His Highness, The Crown Prince of Kuwait, during our meeting in New York. He said, “When you are in need, India is your destination.” The citizens of Bharat and Kuwait have always stood by each other during difficult times and crises. During the Corona pandemic, both countries supported each other at every level. When Bharat needed help the most, Kuwait supplied liquid oxygen to us. His Highness, The Crown Prince, personally stepped forward to inspire everyone to work swiftly.  I am satisfied that Bharat, too, extended its support by sending vaccines and medical teams to help Kuwait fight the crisis. Bharat kept its ports open to ensure there were no shortages of essential food supplies for Kuwait and its surrounding regions.  In June of this year, a heart-breaking incident occurred here in Kuwait—the fire tragedy in Mangaf—which claimed the lives of many Indians. When I heard this news, I was deeply concerned. However, the way the Kuwaiti government extended its support during that time was like that of a true brother. I salute Kuwait’s spirit and compassion.

    Friends,

    This tradition of standing by each other in both happiness and sorrow forms the foundation of our mutual relationship and trust. In the coming decades, we will become even greater partners in prosperity. Our goals are not very different. The people of Kuwait are working towards building New Kuwait, and the people of Bharat are also dedicated to making the country a developed nation by 2047.  Kuwait aims to become a dynamic economy through trade and innovation, and Bharat, too, is focusing on innovation and continuously strengthening its economy. These two goals complement each other.  The innovation, skills, technology, and manpower required for the creation of New Kuwait are all available in Bharat. Bharat’s start-ups, ranging from fintech to healthcare, smart cities to green technologies, can provide cutting-edge solutions for every need of Kuwait. Bharat’s skilled youth can also add new strength to Kuwait’s future journey.

    Friends,

    Bharat has the potential to become the world’s skill capital. Bharat will remain the youngest country in the world for many decades to come. In this context, Bharat has the capacity to meet the global demand for skills. To achieve this, Bharat is focusing on skill development and skill upgrading for its youth, in line with global needs.  In recent years, Bharat has signed migration and employment agreements with nearly two dozen countries, including Gulf nations, Japan, Australia, France, Germany, Mauritius, the UK, and Italy. Countries around the world are also opening their doors to Bharat’s skilled manpower.

    Friends,

    Many agreements are being made with different countries to ensure the welfare and facilities of Indians working abroad. You may be familiar with the e-Migrate portal. Foreign companies and registered agents have been brought onto a single platform through this portal. This makes it easy to identify where there is a demand for manpower, what type of manpower is needed, and which company requires it.  Thanks to this portal, millions of workers have come to Gulf countries in the past 4-5 years. Every such initiative has a single goal—to ensure that the talent from Bharat contributes to the world’s progress and that those who go abroad for work always have the necessary support.  You all in Kuwait will also benefit greatly from Bharat’s efforts in this regard.

    Friends,

    Wherever we live in the world, we respect the country we are in, and we feel immense joy in seeing Bharat reach new heights. You all came from Bharat, lived here, yet you have preserved your Indian identity in your hearts. Now, tell me, which Indian wouldn’t feel proud of the success of Mangalyaan? Which Indian wouldn’t have been overjoyed by the landing of Chandrayaan on the moon? Am I not right? Today, Bharat is advancing with a new spirit. Bharat is now the world’s fifth-largest economy. It is home to the world’s number one fintech ecosystem. Bharat also boasts the world’s third-largest start-up ecosystem and is the second-largest mobile phone manufacturer in the world.

    Let me share a statistic with you, and I’m sure you will be pleased to hear it. In the past 10 years, the length of optical fiber laid across Bharat is eight times greater than the distance between the Earth and the Moon. Today, Bharat is one of the most digitally connected countries in the world. Every Indian is using digital tools from small towns to villages. Smart digital systems in Bharat are no longer a luxury; they are now a part of the everyday life of the common man. Whether it’s enjoying a cup of tea, buying fruits on the street, or making digital payments, Bharat has embraced digital convenience. Ordering groceries, food, fruits, vegetables, or everyday household items is now done in a matter of moments, and payments are made via mobile phones.  People have DigiLocker for storing documents, DigiYatra for seamless travel at airports, and FASTag to save time at toll booths. Bharat is becoming increasingly digitally smart, and this is just the beginning. The future of Bharat lies in innovations that will set the direction for the entire world. The future Bharat will be the hub of global development, the growth engine of the world. The time is not far when Bharat will become the hub of Green Energy, Pharma, Electronics, Automobiles, Semiconductors, Legal, Insurance, Contracting, and Commercial sectors. You will see the major economic centres of the world establishing themselves in Bharat. Bharat will emerge as a massive hub for Global Capability Centres, Global Technology Centres and Global Engineering Centres.

    Friends,

    We consider the entire world to be one family. Bharat is moving forward as a ‘Vishwa Bandhu’ (global friend), thinking of the world’s welfare. The world, too, is acknowledging this spirit of Bharat. Today, on December 21, 2024, the world is celebrating its first World Meditation Day, dedicated to Bharat’s thousands of years of meditation tradition. Since 2015, the world has been celebrating International Yoga Day on June 21, also dedicated to Bharat’s yoga tradition. In 2023, the world celebrated the International Year of Millets, which was made possible through Bharat’s efforts and proposal. Today, Bharat’s yoga is uniting every region of the world. Bharat’s traditional medicine, our Ayurveda, and our Ayush products are enriching global wellness. Our superfoods, millets, and Shri Anna are becoming a major foundation for nutrition and a healthy lifestyle. From Nalanda to the IITs, Bharat’s knowledge system is strengthening the global knowledge ecosystem. Today, Bharat is also becoming a key link in global connectivity. During the G-20 summit held in Bharat last year, the announcement of the India-Middle East-Europe Corridor was made. This corridor is set to provide a new direction for the future of the world.

    Friends,

    The journey of a ‘Viksit Bharat’ (Developed India) is incomplete without your support and the participation of the Indian diaspora. I invite you all to join the resolve for a ‘Viksit Bharat’. The first month of the new year, January 2025, will be a month of many national celebrations. From January 8 to 10 this year, the Pravasi Bharatiya Divas will be held in Bhubaneswar, with people from all over the world coming together. I invite you all to be a part of this event.  On this journey, you can take blessings from Lord Jagannath in Puri. After that, do visit Prayagraj to take part in the Maha Kumbh Mela, which will be held from January 13 to February 26, lasting for about a month and a half. Make sure to return after watching the Republic Day celebrations on January 26. And yes, bring your Kuwaiti friends to Bharat, show them around, and let them experience Bharat. There was a time when Dilip Kumar Saheb inaugurated the first Indian restaurant here. The real taste of Bharat can only be experienced there. So, make sure to prepare your Kuwaiti friends for this experience.

    Friends,

    I know that all of you are very excited about the Arabian Gulf Cup that is starting today. You are eager to cheer for the Kuwait team. I am grateful to His Highness, The Amir, for inviting me as the Guest of Honour for the opening ceremony. This reflects the immense respect that the royal family, the government of Kuwait, have for all of you and Bharat. I hope that you continue to strengthen the Bharat-Kuwait relationship in this way. With this wish, once again, a heartfelt thank you to all of you!

    Bharat Mata ki—Jai!

    Bharat Mata ki—Jai!

    Bharat Mata ki—Jai!

    Thank you very much. 

    DISCLAIMER: This is the approximate translation of the PM’s speech. Original speech was delivered

    MIL OSI Asia Pacific News

  • MIL-OSI New Zealand: Save the Children 2024 IN REVIEW: Why three child killer diseases rose globally this year

    Source: Save the Children

    Three child-killer diseases – dengue, cholera, and mpox – witnessed major resurgences in 2024 fuelled partly by climate crises and conflict, with these illnesses likely to cause significant strains on communities in 2025 without more focused global attention, said Save the Children.
    More than 13,600 people, including children, are suspected or confirmed to have died from these three diseases this year, with cases of dengue and mpox reaching record highs. While there was a slight global decline in cases of cholera, the number of fatal cases of the virus jumped 126% from 2023.
    It was a horror year for dengue fever in 2024, with cases of the mosquito-borne virus reaching the highest number on record at 13.3 million – more than double the 6.5 million cases in 2023 which was itself a record high [1]. Increased urbanisation and changes in climate and temperatures have fuelled the mosquitoes that spread the virus. The World Health Organization estimates that 4 billion people are currently at risk of dengue and related viruses and this will rise to 5 billion by 2050.
    There were nearly half a million cases of cholera this year, with 3,432 deaths recorded by the end of September, when most recent data was available [2]. While the number of cases in 2024 is 16% lower than last year, there has been a 126% spike in deaths, according to the WHO. The increase in mortality is likely due to the location of the outbreaks in conflict-affected areas where access to healthcare is severely compromised, and regions experiencing flooding that has damaged critical infrastructure.
    This year saw a major increase in cases and fatalities from the mpox virus, which was declared a public health emergency of international concern in August 2024 by both the World Health Organization and the Africa Centre for Disease Control. This followed a surge of mpox infections in the Democratic Republic of Congo and surrounding countries in Africa, with a major portion of cases and deaths being children, and a new circulating variety (known as a ‘clade’) of mpox a particular concern to children.
    Beauty, 17, lives with her sister and her parents in an informal settlement in Lusaka, Zambia. Her community was hit by a major cholera outbreak earlier this year. Beauty said:
    “Cholera, this current outbreak, has really impacted me and my family because my father had to stop work because of the outbreak, and my mother – she’s a teacher – she also had to stop work for the same issue. It was challenging for us in terms of finances and surviving, but, to God’s grace, we’re surviving. It’s important to have access to clean water because most of the diseases that happen, they happen because people drink contaminated water. So, if you drink clean water…then you can prevent yourself from getting diseases like cholera.”
    Dr Revati Phalkey, Global Health and Nutrition Director, said:
    “Currently, about half of the world’s population is not fully covered by essential, quality, affordable health services – denying them their right to health committed as part of universal health coverage ambitions. Health systems are under enormous pressure to deliver universal health coverage with the majority of countries experiencing worsening or no significant change in service coverage since the launch of the sustainable development goals in 2015.
    “We need greater global investments to build strong health systems that are able to deliver essential health services especially vaccines and essential medicines while responding to global health emergencies, including emerging issues like mpox.
    “It is time for governments and the international community to step up and ensure all children are protected against disease and have access to adequate health services when they need them and where they need them. Every child has the right to survive and thrive and it is our collective responsibility to deliver on this.”
    While these headline grabbing illnesses saw rapid increases in cases or death rates in 2024, pneumonia remains the leading infectious cause of death among children under 5, killing about 500,000 children a year.
    However, new estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) show that the number of children dying from pneumonia dropped sharply from 693,000 in 2019 to 502,000 in 2021, the lowest number ever recorded. This 28% reduction is being attributed to the impact of COVID-19 restrictions and underscores the power of preventing the spread of infection. That said, the impact of the climate crisis is likely to increase respiratory diseases such as pneumonia once again, affecting children the most impacted by inequality and poverty.
    Meanwhile, children are particularly vulnerable to dengue fever because their immune systems are weaker than adults and they tend to play outside where there is less protection against the mosquitos. Children under five are at particular risk of developing dehydration and shock from dengue if they contract the illness, and children are most impacted if the illness incapacitates or kills their parents and other caregivers.
    Mpox causes fever, rash and lesions all over the body, severe headaches and fatigue, with some children developing respiratory problems and difficulty swallowing. In severe cases, mpox can lead to sepsis, a life-threatening response to infection that requires immediate specialist medical attention.
    Cholera takes a heavier toll on young children, especially those under the age of 5 who are at higher risk of severe dehydration and death during cholera outbreaks.
    Around the world, Save the Children provides public healthcare for children and their families, including treatment for diseases like dengue, cholera and mpox, and works with schools and communities to improve awareness on how to prevent infection.
    • [1] Total number of dengue-related deaths globally in 2024 – 9600 see [2]; Total number of cholera and acute water diarrhea deaths in 2024 – 4018 see [3]; Total number of Mpox deaths in 2024 – 57 see [4]; Total number of deaths of the three diseases in 2024 – 13,675.
    • [2] According to the WHO Global Dengue Surveillance, since the beginning of 2024, over 13.3 million dengue cases and over 9600 dengue-related deaths have been reported globally. https://worldhealthorg.shinyapps.io/dengue_global/
    • [3] According to the WHO, from 1 January to 27 October 2024, a cumulative total of 486 760 cholera and acute watery diarrhoea cases and 4018 deaths were reported from 33 countries across five WHO regions. While the number of cases reported in October 2024 is 42% lower than the same period in 2023, the number of deaths has increased by 54% – reflecting severe response challenges in outbreak settings [ https://www.who.int/publications/m/item/multi-country-outbreak-of-cholera–external-situation-report–20—20-november-2024]
    • [4] According to the WHO, as of 1 December 2024, in Africa there were 13 171 confirmed cases of Mpox, including 57 deaths reported by 20 countries. https://worldhealthorg.shinyapps.io/mpx_global/

    MIL OSI New Zealand News

  • MIL-OSI Asia-Pac: Health, medical research supported

    Source: Hong Kong Information Services

    The Health Bureau today said the Government provides comprehensive and dedicated support for health and medical research projects, research infrastructure and research capacity building in Hong Kong through setting up the Health & Medical Research Fund (HMRF).

    Making the statement in regard to some recent media reports on the Government’s funding support for infectious diseases-related research, the bureau emphasised that the Government has all along been highly supportive of the local health and medical sector to conduct health and medical research, including those related to infectious diseases.

    The bureau noted that funding commitment to the HMRF, established in 2011, has been increased repeatedly and the approved amount has increased to $4.22 billion to support Government-commissioned programmes and investigator-initiated projects. Among them, those related to infectious diseases research amount to $1.2 billion.

    Such projects involved six commissioned programmes on infectious diseases with approved funding of $792 million, covering COVID-19, Middle East Respiratory Syndrome (MERS), influenza, avian flu, swine flu and other respiratory infectious diseases, human papilloma virus and anti-microbial resistance research.

    The above-mentioned commissioned programmes include a total of $556 million since April 2020 to support 105 individual COVID-19 related research studies from bench to bedside and at the community level through application of new technologies.

    These studies provide new evidence to support the Government to promptly tackle the COVID-19 epidemic by formulating health policies, identifying the transmission chains, implementing control measures, improving clinical management as well as developing and promoting the vaccination programme.

    One of the research projects successfully developed the sewage testing approach for quantitative detection of SARS-CoV-2, providing an important indicator for the Government to keep track of virus activity in the community during the COVID-19 epidemic.

    For investigator-initiated projects, infectious disease has always been one of the thematic priorities. As of end September 2024, a total of about 400 research studies have been funded amounting to $424 million.

    Such studies covered the prevention, detection, diagnosis and management of various infectious diseases, such as the hepatitis virus, tuberculosis, AIDS, and those related to preparedness and response to a pandemic and epidemic.

    The Government encourages researchers to continue to leverage the HMRF to amplify the value of their research projects into full play and usher in considerable and sustainable positive impacts on health policy making and implementation with their research outcomes and to unleash new quality productive forces.

    On combating infectious diseases, the Government will continue to support the health and medical sector in conducting related research in order to enhance the capacity in surveillance, early detection, prevention and control.

    MIL OSI Asia Pacific News

  • MIL-OSI NGOs: South Sudan receives thousands of displaced and injured people fleeing intensified war in Sudan

    Source: Médecins Sans Frontières –

    Juba – As South Sudan receives a massive influx of tens of thousands of people fleeing the intensified war in Sudan, Médecins Sans Frontières (MSF) is scaling up its response to the humanitarian crisis in Renk and surrounding informal settlements along the border. Over the last weeks the number of recently displaced people has surpassed 80,000, including hundreds of people with war wounds. MSF is calling for immediate, coordinated humanitarian and medical support for displaced people to address critical gaps and prevent further suffering.

    Over 5,000 people have crossed into South Sudan each day since the beginning of December, as the fighting escalates near the border in Sudan’s White Nile, Blue Nile, and Sennar states. The influx of people into Renk town and surrounding areas has overwhelmed an area that is already scarce of resources, leaving displaced people in crisis.  

    “We have added 14 tents around the hospital to make space for the war-wounded patients that are arriving at Renk County hospital,” says Emanuele Montobbio, MSF emergency coordinator in Renk. “There is no place for other tents in the surroundings, while patients and their families keep coming to the hospital.”

    “We are working alongside the International Committee of the Red Cross (ICRC) to treat war-wounded patients and manage the growing influx of critical cases and the mass casualty response in pre- and post-operative care wards, but the situation is completely overwhelming and it’s not enough,” he says. “Just a few dozen people have been treated with surgical interventions and tetanus vaccinations in recent weeks, while over 100 wounded patients, many with serious injuries, still await surgery.”

    Outside the transit centres within Renk and in informal settlements, thousands are forced to live under trees or in makeshift shelters, with limited access to food, clean water, healthcare or any other basic services. The poor water and sanitation conditions are heightening the risk of disease outbreaks at a time when Renk is already experiencing a cholera outbreak.  

    “Immediate action must be taken,” says Roselyn Morales, MSF deputy medical coordinator in South Sudan, following the team’s assessment on the ground. “Thousands of people are living in dire conditions under the open sky in informal settlements, facing critical shortages of food, clean water, shelter and healthcare.”

    A stagnant pool of water is the only easily accessible water source in the Jerbana informal settlement. Both humans and livestock depend on this pool, which is gradually drying up. South Sudan, 19 December 2024.
    Isaac Buay/MSF

    “We urgently call on both South Sudanese authorities and international organisations to rapidly scale up their response in Renk and beyond, ensuring that the essential and lifesaving needs of the affected population are addressed without delay,” she says.

    The two transit centres in Renk, which are designed to accommodate a maximum of 8,000 people, are now sheltering over 17,000. While most returnees and refugees initially entered South Sudan through the official Joda border crossing, an increasing number are now crossing through informal routes to the east of Renk. More than 82,000 new arrivals have been recorded in areas including Joda, Duku Duku, Jerbana, Shemmedi, Gosfami, and Atam.  

    “Our village was in flames,” says Alhida Hammed, who is displaced from Sudan’s Blue Nile state and is currently under treatment for a gunshot wound at Renk County hospital. “The houses were blazing, and everyone was running in different directions. We have been displaced and now live under a tree. I have no desire to return home. Home is no longer a home—it is filled with bad memories.” 

    “I used to only hear about air raids, but recently, it became a reality,” says Bashir Ismail, who is from Mosmon in Sudan’s Blue Nile state. “I was at the market buying some items when the bombing started. Something hit me in the chest—it was the most painful experience of my life. I was so disoriented that it felt like I had lost my memory. The next thing I knew, I was in Renk County hospital.” 

    MSF is deploying mobile clinics to provide general healthcare in informal settlements in Gosfami, Atam, Jerbana and Joda, where displaced people are concentrated. On 17 December alone, MSF teams conducted over 250 medical consultations in Gosfami and referred severely ill people to Renk County hospital.

    We are also launching activities in response to the urgent need for water and sanitation in Atam and Jerbana. Additionally, relief items have been delivered to these areas for distribution to 2,500 displaced families. However, despite these efforts, the response remains insufficient due to the absence of other humanitarian organisations in these informal settlements, which has left a significant gap in support for displaced people.

    MIL OSI NGO

  • MIL-OSI Russia: 23rd meeting of the Intergovernmental Commission on Economic Cooperation between the Russian Federation and the Republic of Armenia

    Translation. Region: Russian Federation –

    Source: Government of the Russian Federation – An important disclaimer is at the bottom of this article.

    The meeting was held under the joint chairmanship of Deputy Prime Minister of the Russian Federation Alexey Overchuk and Deputy Prime Minister of the Republic of Armenia Mher Grigoryan.

    Previous news Next news

    23rd meeting of the Intergovernmental Commission on Economic Cooperation between the Russian Federation and the Republic of Armenia

    The 23rd regular meeting of the Intergovernmental Commission on Economic Cooperation between the Russian Federation and the Republic of Armenia was held in Moscow under the joint chairmanship of Deputy Prime Minister of the Russian Federation Alexey Overchuk and Deputy Prime Minister of the Republic of Armenia Mher Grigoryan.

    The parties summed up the results of bilateral cooperation in trade and economic spheres, energy, industry, transport, agriculture, finance, healthcare, culture, science, interregional cooperation, education and tourism.

    “Our trade and economic relations continue to be on the rise. Mutual trade between Russia and Armenia, according to data for 10 months of 2024, amounted to 10.2 billion dollars. This is more than twice as much as the same indicator last year,” noted Alexey Overchuk, emphasizing that in order to implement trade and economic relations, the countries have almost completely switched to settlements in national currencies – the share of the Russian ruble in mutual settlements has reached 96.3%.

    The Russian Federation is one of the main investors in the Armenian economy. Investments in industrial projects in the Republic of Armenia have reached $3.4 billion. More than 40 large Russian companies operate in Armenia, some of them are the largest taxpayers in the state budget.

    “In addition to direct investments, Eurasian development institutions are also actively working,” said the Deputy Prime Minister. “Active work is underway here, including in support of the “Crossroads of the World” initiative, which was put forward by the Prime Minister of the Republic of Armenia Nikol Vovaevich Pashinyan.”

    The Chairman of the Russian part of the commission also noted that in July 2024, with the assistance of Russian Railways, the railway between Armenia and Georgia, damaged by flooding, was restored in the shortest possible time – the only railway connecting Armenia with the outside world, which is an important channel for delivering vital goods to Armenia.

    “All these investments and projects are being implemented with the aim of strengthening connectivity in the Eurasian region and the South Caucasus, in particular, integrating Armenia into the new value chains emerging in Eurasia and realizing the transport and logistics potential that the Republic of Armenia has, with unwavering respect for its sovereignty and jurisdiction,” Alexey Overchuk said in his speech.

    In the context of the work of Eurasian development institutions, the Deputy Prime Minister also noted the implementation of the irrigation systems modernization project: mechanical irrigation has been replaced by gravity irrigation, which provides annual energy savings. 5 main and 22 inter-farm canals have been restored. Work on the restoration and construction of intra-farm irrigation systems in 105 settlements of the Republic of Armenia has been completed.

    “Two weeks ago, our specialists agreed to assess the technical condition of eight bridges damaged by the floods in Lori and Tavush. All work will be completed as soon as possible, and we expect that by the end of the year, their results will be submitted to the Ministry of Territorial Administration and Infrastructure of the Republic of Armenia,” the Deputy Prime Minister said.

    During the meeting, the active development of cooperation in the humanitarian sphere was emphasized.

    “Today we are signing an intergovernmental Agreement on the conditions of operation of the Russian-Armenian University in the Republic of Armenia. This is one of the leading universities in Armenia, where more than 5 thousand students study, mastering 123 educational programs, 80 of which are taught according to Russian educational standards,” the Deputy Prime Minister emphasized.

    The university’s research and teaching staff includes 82 doctors and 332 candidates of science. The university’s structure includes 9 institutes, 31 departments and 12 laboratories.

    The University cooperates with the Joint Institute for Nuclear Research, the Institute for System Programming of the Russian Academy of Sciences, the St. Petersburg Polytechnic University and other Russian scientific centers. Research projects are implemented in such areas as bioinformatics, genomic research, quantum nanophotonics, biochemistry and biotechnology.

    Work continues to provide opportunities to receive education according to Russian standards in the educational and sports complex, which includes a school for 700 students, built in Yerevan as part of the Gazprom for Children social program.

    The countries pay great attention to cooperation in the field of culture. Since 2023, a program to support Russian theaters abroad has been implemented, within the framework of which the Yerevan State Russian Drama Theater named after Stanislavsky was provided with financial assistance for the acquisition of stage equipment and the creation of new productions based on works of Russian classics. The Moscow Parajanov Theater, with the support of the Ministry of Culture of Russia and the Cultural Center of the Armenian Embassy in Russia, held a large-scale festival “Parajanov Fest”.

    Bilateral cooperation in the field of creative education is developing. Within the framework of the International Student Festival of VGIK, 38 films participating in the festival were screened at the Russian-Armenian University.

    In pursuance of the agreements reached at the meeting of the intergovernmental commission, the second Russian-Armenian Forum of Education in the Sphere of Culture was held in Moscow in December 2024.

    Cooperation in the healthcare sector is being strengthened, including within the framework of annual Russian-Armenian forums on healthcare. The ninth Russian-Armenian forum on healthcare, dedicated to issues of maternal and child health, was held on December 16, 2024 in Yerevan. During the forum, the system of extended perinatal screening developed and successfully applied in Russia was presented.

    Russia and Armenia are developing mutual tourism. In January-September 2024, the number of trips of Russian tourists to Armenia amounted to 715.8 thousand, and Armenian tourists to Russia – 266 thousand.

    Speaking about cooperation in multilateral formats, primarily through the Eurasian Economic Union, the Deputy Prime Minister noted that the union has become a real guarantor of Armenia’s energy and food security, as well as its technological development.

    “The Union countries are the key sales market and the key supplier to the Armenian market. The EAEU accounts for 56% of Armenia’s food exports, 80% of machinery and equipment exports, 67% of chemical exports, and 56% of textile exports. The EAEU also provides 72% of energy imports, 49% of precious metal imports, 38% of food imports, and 34% of timber imports. During its membership in the Union, the export of industrial goods from Armenia has grown 15-fold, and food exports from Armenia have grown 4-fold. Since joining the EAEU in 2015, Armenia’s per capita GDP has grown almost 2.4-fold. This was made possible by the benefits of a common goods market, low prices for agricultural raw materials and energy, a convenient migration regime, and a common services market,” said Alexey Overchuk.

    Following the meeting, the protocol of the 23rd meeting of the Intergovernmental Commission on Economic Cooperation between the Russian Federation and the Republic of Armenia was signed.

    The parties also signed an Agreement between the Government of the Russian Federation and the Government of the Republic of Armenia on the conditions for the operation of the Russian-Armenian University in the Republic of Armenia, a State Purchase Agreement for a polyvalent, cultured, sorbed, inactivated foot-and-mouth disease vaccine, an Agreement between the Government of the Russian Federation and the Government of the Republic of Armenia on the conditions for the operation of the Educational and Sports Complex of Gazprom Armenia CJSC in Yerevan, and a work plan for the Russian-Armenian Business Council for 2025.

    Please note: This information is raw content directly from the source of the information. It is exactly what the source states and does not reflect the position of MIL-OSI or its clients.

    MIL OSI Russia News

  • MIL-OSI USA: FDA Roundup: December 20, 2024

    Source: US Department of Health and Human Services – 3

    For Immediate Release:

    Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:

    • Today, the FDA provided answers to a set of FAQs about software functions that may be described as clinical decision support (CDS). The FAQs are intended to help sponsors identify whether their CDS software may or may not meet the definition of a medical device, as described in the FDA’s final guidance for Clinical Decision Support Software. Additionally, the FDA updated the list of authorized Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices; totaling 1,016. The list is not a comprehensive resource of medical devices that incorporate AI/ML. The devices in this list have met the FDA’s applicable premarket requirements.
    • On Monday, the FDA approved a premarket approval application (PMA) 180-day supplement for the OraQuick Human Immunodeficiency Virus (HIV) Self-Test. This approval represents a labeling change to lower the approved age to individuals who are 14 to 17 years of age and older for the OraQuick HIV Self-Test to provide access to HIV testing to adolescents. The original approval of the OraQuick HIV -Self Test was indicated only for individuals who are 17 years and older.

      This is the first approval for an over-the-counter HIV test in adolescents. Availability will help in the detection of HIV among the adolescent population. 

      The OraQuick HIV Self-Test is a single home-use test to detect antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2) in human oral fluid specimens.  This test kit includes of a test stick (device) to collect the specimen, a test tube (vial) to insert the test stick (device) and complete the test, testing directions, booklet titled, “HIV, Testing and Me”, and access to the OraQuick Support Center to assist users with questions about performing the test, or to connect them with a healthcare provider in their area.

      The OraQuick HIV Self-Test is not intended to be used with specimens other than oral fluid. Individuals should obtain a confirmatory test in a medical setting.

      Complete instructions for use can be found on the FDA’s website here.

    • On Thursday, the FDA Office of Inspections and Investigations published a Viewpoint article titled Partnership in Action: Creating Safeguards for Imported Products Entering the United States in the Pacific Islands by Dan Solis, Assistant Commissioner for Import Operations. The article highlights the FDA’s work in Guam to ensure that imported products entering the U.S. through the Pacific Rim are safe for consumers. The Pacific Rim is a strategically significant location when it comes to ensuring the safety of products bound for consumers in the United States, as a little more than a third of global products coming into our country originate in the Asia-Pacific Region. You can learn more about the FDA’s efforts in the Pacific Islands by listening to OII Podcasts | FDA. The 5-Part series is called, Guam Series: FDA Presence and Impact in Pacific Islands.
    • On Thursday, the FDA updated the outbreak advisory for Salmonella Typhimurium infections linked to cucumbers with additional cases. The FDA’s investigation remains ongoing.
    • On Thursday, the FDA approved Tryngolza (olezarsen), used with diet, to reduce triglycerides (TG) in adults with familial chylomicronemia syndrome (FCS). FCS is a rare, genetic disorder that prevents the body from breaking down fats (TG) in the bloodstream. People with FCS can have TG levels in the thousands. These high TG levels can cause severe abdominal pain, inflammation of the pancreas (acute pancreatitis), and fatty deposits in the skin (xanthomas). Some of these symptoms, specifically acute pancreatitis, can be life-threatening. This is a first-in-class approval, meaning Tryngolza uses a new mechanism of action, or works differently in the body, than other therapies currently used to treat FCS.  The most common adverse reactions were injection site reactions, decreased platelet count, and arthralgia.
    • On Thursday, the FDA re-evaluated its determination from October 2, 2024, on the status of the tirzepatide shortage. The agency issued a new decision determining the tirzepatide injection shortage is resolved. The FDA’s determination is based on its analysis of all the information before the agency.  
    • On Wednesday, the FDA posted the latest video in the FDA In Your Day series. This one focuses on pertussis, also known as whooping cough, and what consumers can do to protect themselves and those around them.
    • On Wednesday, the FDA approved Ryoncil (remestemcel-L-rknd) an allogeneic bone marrow-derived mesenchymal stromal cell (MSC) therapy, for steroid-refractory acute graft versus host disease (SR-aGVHD) in pediatric patients 2 months of age and older. Ryoncil is the first FDA-approved MSC therapy. The most common nonlaboratory adverse reactions (incidence ≥20%) were viral infectious disorders, bacterial infectious disorders, infection – pathogen unspecified, pyrexia, hemorrhage, edema, abdominal pain and hypertension.
    • On Wednesday, the FDA approved Ensacove (ensartinib, Xcovery Holdings, Inc.) for adult patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) who have not previously received an ALK-inhibitor. The most common adverse reactions (≥20%) were rash, musculoskeletal pain, constipation, cough, pruritis, nausea, edema, pyrexia, and fatigue.
    • On Wednesday, the FDA shared our latest testing results for per- and polyfluoroalkyl (PFAS) substances in clams as follow up to the agency’s findings in the 2022 PFAS in seafood survey. Between October 2022 and September 2024, the FDA collected and analyzed 12 samples of processed clams with China as the country of origin. All 12 samples had detectable levels of at least one type of PFAS.
    • On Wednesday, the FDA issued a letter to food manufacturers that Amanita muscaria (A. muscaria), its extracts, and certain of its constituents (muscimol, ibotenic acid, and muscarine) are not authorized for use as ingredients in conventional food. A. muscaria and its constituents have been used in foods intended to have hallucinogenic effects, sometimes marketed as “psychedelic edibles”, “legal psychedelics” or “mushroom edibles”. After reviewing the available information about A. muscaria and its constituents, the FDA concluded that they do not meet the safety standard for use in food and that their use as food ingredients may be harmful. We also recommend that people avoid eating foods with these ingredients. The FDA’s assessment of chemicals in the food supply is part of our commitment to food safety and public health.
    • On Wednesday, the FDA updated the advisory for the outbreak of E. coli illnesses linked to certain sizes and brands of organic whole and baby carrots supplied by Grimmway Farms. According to CDC, as of December 18, 2024, this outbreak is over. The FDA conducted inspections at Grimmway Farms and collected environmental samples. Two environmental samples collected outside were positive for Shiga toxin-producing E. coli (STEC). Although both strains of E. coli detected in the samples are capable of causing human illness, neither match the strain of E. coli causing illnesses in this outbreak. The FDA is working with Grimmway Farms on corrective and preventive actions. The FDA’s investigation is complete.
    • On Tuesday, the FDA and the U.S. Department of Agriculture announced a charter that details how the two agencies work together to determine the appropriate agency to regulate the small number of animal biologicals for which jurisdiction may be unclear. Representatives from the FDA and USDA originally signed a Memorandum of Understanding in 2013 that outlined which animal biologicals each would regulate. Since 2013, science has continued to advance, and the jurisdiction of some products is not clear under the MOU. The charter includes a flowchart to help clarify which agency will regulate a given product, as well as information on how to request a jurisdiction determination from the FDA and USDA for animal biologicals.

    Related Information

    ###

    Boilerplate

    The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, radiation-emitting electronic products, and for regulating tobacco products.


    Inquiries

    Consumer:
    888-INFO-FDA

    MIL OSI USA News

  • MIL-OSI Asia-Pac: “JAM(Jan Dhan, Aadhar, Mobile)TRINITY and digital revolution: A Decade of Financial Inclusion, Transparency and Corruption Free India”

    Source: Government of India

    “JAM(Jan Dhan, Aadhar, Mobile)TRINITY and digital revolution: A Decade of Financial Inclusion, Transparency and Corruption Free India”

    Ayushman Bharat: Path towards an Inclusive Healthcare Paradigm

    There are more than 54 crore Jan Dhan Yojana accounts, with a total deposit balance of approximately ₹2.39 lakh crore- an increase of over 15 times since its inception.

    37.02 crore RuPay cards have been issued to PMJDY account holders

    In FY 2023-24, UPI transactions reached ₹200 lakh crore, a 138% increase from 2017-18.

    UPI now operational in seven countries and more than 40% of the global real-time payment transactions are happening in India.

    As on 30.11.2024, approximately 36 crore Ayushman cards have been created across the country and a total of around 29,929 hospitals are empaneled under the scheme including 13,222 private hospitals

    AB-PMJAY is presently implemented in 33 States/UTs across the country.

    Posted On: 20 DEC 2024 7:29PM by PIB Delhi

    Modi Government has been working for the poor and more than 200 schemes have been launched in the last 10 years for the welfare of the 140 crore people of the nation, said Union Minister of State for Corporate Affairs and Road, Transport and Highways,Shri Harsh Malhotra. Shri Malhotra was addressing a Press Conference on impact of path breaking reforms of JAM(Jan Dhan Yojna, Aadhar& Mobile) Trinity Schemes,Digital Transactions and AYUSHMAN BHARAT-PM JAY.

    Shri Malhotra stated that under the visionary leadership of PM Shri Narendra Modi, Pradhan Mantri Jan Dhan Yojana (PMJDY) has solved a significant portion of India’s population by bringing them into the banking ecosystem.  At present, there are more than 54 crore accounts, with a total deposit balance of approximately ₹2.39 lakh crore- an increase of over 15 times since its inception. The scheme has been particularly successful in rural ,semi-urban areas and amongst women, with around 66% of accounts coming from these regions. Furthermore, 37.02 croreRuPay cards have been issued to PMJDY account holders, with the average deposit per account rising significantly, reflecting increased usage and savings behaviour. The World Bank has also acknowledged that India has achieved its financial inclusion goals in just six years, a feat that would have taken 47 years without its advanced Digital Public Infrastructure. 
     

    PM-Jan Dhan Yojna  coupled with JAM Trinity has become the world’s largest Financial inclusion program. Now, every rupee released from central Government   reaches  to the intended beneficiary directly without any middlemen which has further led to the enhancement of Indian Economy . The once neglected poor section of the country has been  linked with the rising Indian Economy.This has been made possible with a mission-mode approach that involved both the government and the public.The Minister highlighted that JAM Trinity has driven the nation’s digital revolution and enhance transparency within the financial ecosystem. The government’s focus for the initiative is maximising value for every rupee spent, empowering the poor, and ensuring technology penetration among the masses has been achieved.The JAM Trinity has played a pivotal role in facilitating this progress, enabling more effective and inclusive financial transactions, particularly through Direct Benefit Transfers (DBT). This system has not only ensured subsidies and benefits reach the underprivileged directly but also reduced corruption and eliminated fake beneficiaries. The average deposits in the Jan Dhan Accounts as on 14.8.2024 is Rs 4352. The government has fought against poverty on all fronts and consequently,25 crore have come out of poverty in the last 10 years. Delhi alone has 65 lakh PM Jan Dhan Accounts with a total deposit of Rs 3114 crores along with 50 lakh beneficiaries of RuPAY Cards. 2,59,000 women have been benefited from the PM Ujjwala Scheme

    Minister of State emphasised that the success of PMJDY and the JAM trinity has brought greater financial inclusion, empowering citizens with access to banking services while promoting transparency and curbing corruption.PMJDY has not only transformed the financial landscape for millions of Indians but also paved the way for India to emerge as a global leader in digital financial inclusion. About 10 crore fake beneficiaries have been weeded out from the system  which has helped in prevent Rs 2.75 lakh crore from going into wrong hands.

    Shri Malhotra stated that India’s digital payment landscape has also seen exponential growth, with UPI transactions expanding rapidly. In FY 2023-24, UPI transactions reached ₹200 lakh crore, a 138% increase from 2017-18. This growth in digital payments has positioned India as a global leader in this domain, with UPI now operational in seven countries, further boosting financial inclusion and remittance flows. Through the continued expansion of digital payment solutions and initiatives like UPI, India is setting new benchmarks for economic empowerment and financial transparency and also mentioned that more than 40% of the global real-time payment transactions are happening in India.

    The Government’s focus on inclusive healthcare ensured that, India was just the fifth country to develop the COVID Vaccine and successfully executed  the world’s largest vaccine program in which 221 crore doses were administered to the people of the nation.

    Minister of State highlighted that Ayushman Bharat- PradhanMantri Jan Arogya Yojana (AB-PMJAY) which was launched on 23.09.2018 with an aim to provide health cover of Rs. 5 lakh per family per year for secondary and tertiary care hospitalisation. AB-PMJAY is presently implemented in 33 States/UTs across the country.

    In March 2024, 37 lakh families of ASHA, Anganwadi Worker and Anganwadi Helpers were also included in the scheme.

    Shri Malhotra mentioned that on 29.10.2024, the Government of India expanded the scheme to provide free treatment benefits of up to ₹5 lakh per year on a family basis to all senior citizens aged 70 years and above, irrespective of their socio-economic status. As on 30.11.2024, approximately 36 crore Ayushman cards have been created across the country and a total of  around 29,929 hospitals are empaneled under the scheme including 13,222 private hospitals, to ensure delivery of quality healthcare services to the beneficiaries. Further, a total of around8.39 crore hospital admissions worth aroundRs. 1.16 lakh crore have been authorized under the scheme.

    ****

    DSK

    (Release ID: 2086611) Visitor Counter : 32

    MIL OSI Asia Pacific News

  • MIL-OSI Europe: Written question – Management of invasive species – E-002927/2024

    Source: European Parliament

    13.12.2024

    Question for written answer  E-002927/2024
    to the Commission
    Rule 144
    Sebastian Everding (The Left), Anja Hazekamp (The Left), Tilly Metz (Verts/ALE)

    Article 19(3) of Regulation (EU) No 1143/2014 on invasive alien species (IAS) provides that Member States must ensure that animals are spared any avoidable pain, distress or suffering when implementing management measures. Safe and humane non-lethal management methods such as immunocontraceptive vaccines and oral contraceptives are available or could be further developed and assessed to manage IAS populations, reducing the use of cruel lethal methods and potentially being more effective. When available, however, these methods cannot be implemented because the regulation also prevents the release of kept IAS animals.

    Can the Commission clarify:

    • 1.Could animal IAS be released after being neutered and could animal IAS be released after being temporarily contained for the purpose of immunocontraceptive vaccine injection?
    • 2.How can the legislation prevent the use of inhumane methods when alternatives exist and why does it provide for such a restrictive framework for the use of alternatives?
    • 3.Are there any plans for funding opportunities for developing, testing and implementing innovative humane management methods, including fertility control?

    Submitted: 13.12.2024

    Last updated: 20 December 2024

    MIL OSI Europe News

  • MIL-OSI USA: FDA Approves First Medication for Obstructive Sleep Apnea

    Source: US Department of Health and Human Services – 3

    For Immediate Release:

    Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity, to be used in combination with a reduced-calorie diet and increased physical activity.

    “Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical Care in the FDA’s Center for Drug Evaluation and Research. “This is a major step forward for patients with obstructive sleep apnea.”

    OSA occurs when a person’s upper airway becomes blocked, causing pauses in breathing during sleep. While OSA can affect anyone, it is more common in people who have overweight or obesity. Zepbound works by activating receptors of hormones secreted from the intestine (glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)) to reduce appetite and food intake. By reducing body weight, studies show that Zepbound also improves OSA.

    Zepbound’s approval for moderate to severe OSA in adults with obesity is based on two randomized, double-blind, placebo-controlled studies of 469 adults without type 2 diabetes. One study enrolled participants using positive airway pressure (PAP), the standard of care for moderate to severe OSA, and one study enrolled participants unable or unwilling to use PAP. In both studies, participants randomly received either 10 or 15 milligrams of Zepbound or placebo once weekly for 52 weeks. The primary measure of efficacy was the change from baseline in the apnea hypopnea index (AHI), a measurement of how many times a person stops breathing (apnea) or breathes shallowly (hypopnea) per hour during sleep, at week 52. After 52 weeks of treatment in both studies, participants who received Zepbound experienced a statistically significant and clinically meaningful reduction in events of apnea or hypopnea as measured by AHI compared with placebo, and greater proportions of participants treated with Zepbound achieved remission or mild OSA with resolution of symptoms compared to placebo. Participants treated with Zepbound had a significant decrease in body weight compared with placebo at 52 weeks. The improvement in AHI in participants with OSA is likely related to body weight reduction with Zepbound.  

    Zepbound can cause side effects such as nausea, diarrhea, vomiting, constipation, abdominal (stomach) discomfort and pain, injection site reactions, fatigue, hypersensitivity (allergic) reactions (typically fever and rash), burping, hair loss and gastroesophageal reflux disease.

    Zepbound causes thyroid C-cell tumors in rats. It is unknown whether Zepbound causes such tumors, including medullary thyroid cancer, in humans. Zepbound should not be used in patients with a personal or family history of medullary thyroid cancer or in patients with Multiple Endocrine Neoplasia syndrome type 2.

    Zepbound should not be used in patients with a history of severe allergic reaction to tirzepatide (its active ingredient) or to any of its other ingredients. Patients should stop Zepbound immediately and seek medical help if a severe allergic reaction is suspected.

    Zepbound also contains warnings for inflammation of the pancreas (pancreatitis), gallbladder problems, hypoglycemia (blood sugar that is too low), acute kidney injury, diabetic retinopathy (damage to the eye’s retina) in patients with type 2 diabetes mellitus, suicidal behavior or thinking, and pulmonary aspiration during general anesthesia or deep sedation. Patients should discuss with their health care provider if they have symptoms of pancreatitis or gallstones. If Zepbound is used with insulin or a medication that causes insulin secretion, patients should speak to their health care provider about potentially lowering the dose of these other medicines to reduce the risk of hypoglycemia. Health care providers should monitor patients with kidney disease, diabetic retinopathy and depression or suicidal behaviors or thoughts. Patients taking Zepbound should inform healthcare providers of any planned surgeries of procedures.

    Zepbound received Fast Track, Priority Review and Breakthrough Therapy designations for this indication.

    The FDA granted the approval to Eli Lilly and Co.

    ###

    Boilerplate

    The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, radiation-emitting electronic products, and for regulating tobacco products.


    Inquiries

    Consumer:
    888-INFO-FDA

    MIL OSI USA News

  • MIL-OSI USA: Schatz: Robert F. Kennedy Jr., Whose Dangerous Lies Fueled Measles Outbreak in Samoa & Caused Preventable Deaths, Unqualified To Lead HHS

    US Senate News:

    Source: United States Senator for Hawaii Brian Schatz
    WASHINGTON – U.S. Senator Brian Schatz (D-Hawai‘i) took to the Senate floor today to detail how President Donald Trump’s nominee for Secretary of Health and Human Services, Robert F. Kennedy Jr., spread dangerous lies about vaccines which directly led to disease outbreaks and caused preventable deaths. Schatz recounted the story of how Kennedy traveled to Samoa in 2019 to discourage people from taking the measles vaccine which ultimately led to an outbreak in which thousands of people were infected and 83, mostly children, died.
    “In 2019, he flew to Samoa to discourage people from taking the measles vaccine, deepening hesitancy that was already building. And it worked,” said Senator Schatz. “Vaccination rates for eligible 1-year-olds fell to lower than 33%. And just 5 months later, Samoa found itself in the middle of a measles outbreak. Over 5,000 people got the measles. 83 people died.”
    Senator Schatz added, “Yes, this is a question of character and competence. But it is also a question of life or death. And who we want in charge, making decisions, when lives are on the line. And it’s our job, here in the Senate, to make damn sure that person isn’t RFK Jr.”
    The full text of Senator Schatz’s remarks, as prepared for delivery, is below. Video is available here.
    You’d think the person nominated to lead our nation’s top health department – an agency with a budget of over 2 trillion dollars and responsible for running everything from Medicare to vaccine trials. You’d think that person would at least be interested, if not experienced, in curing diseases and promoting public health. That they’d follow science and work to build the public’s trust in it. Robert F. Kennedy Jr. is none of those things.
    For the first time ever, we might have a health secretary who’s actively fueled disease outbreaks. He’s literally made a career out of lying about the safety of basic vaccines. And it is not an exaggeration to say: lives will be lost if this man gets confirmed. He has cost lives pretending to be a public health expert before. And he will do it again if he becomes the next health secretary.
    This is not some random dude with his buddies kicking around wacky ideas for the hell of it. He’s a Kennedy, with an enormous fortune, parachuting into countries to tell flat out lies and stop people from taking life-saving vaccines.
    In 2019, he flew to Samoa to discourage people from taking the measles vaccine, deepening hesitancy that was already building. And it worked. Vaccination rates for eligible 1-year-olds fell to lower than 33%. And just 5 months later, Samoa found itself in the middle of a measles outbreak. Over 5,000 people got the measles. 83 people died.
    Aside from spreading baseless lies about vaccines, RFK Jr. has regularly spouted all kinds of deranged conspiracy theories, including that COVID-19 was “targeted to attack Caucasians and black people. The people who are most immune are Ashkenazi Jews and Chinese.” He’s also claimed – without any evidence – that antidepressants are to blame for mass shootings and that chemicals in our water are turning kids gay.
    His plans to remake the Department of Health and Human Services are equally terrifying. He wants to revoke approvals for the polio and Hepatitis B vaccines for children and roll back guidance on other vital vaccines. There’s a reason we haven’t had to think about these awful, painful diseases in a long, long time. It’s because we’ve successfully vaccinated our way out of outbreaks.
    He’s also vowed to fire hundreds of federal health researchers and scientists and stop all research into infectious diseases and vaccine development. Because “we’re going to give infectious disease a break for about eight years.” We’re going to give diseases a break.
    This man, in his views and his actions, is as dangerous as they come. You wouldn’t put him in charge of a local clinic – let alone our country’s entire health system.
    And look, I get it. Some people hear his critiques of our food system and agree with him. Our food system is broken. And people are getting sick because of it. We’ve subsidized the wrong things for so long that you can find an unhealthy meal faster and for cheaper than a healthy one. Ultra-processed foods are everywhere. Healthy, hearty meals are harder to come by. And that has to change. But we don’t fix that problem by inviting a measles or mumps outbreak. We don’t have to voluntarily conjure up the horrors of polio in the name of cleansing our diet. That’s a false choice I refuse to make.
    There are many people – including my friend, Senator Cory Booker – who are working to solve this problem with the seriousness and the thoughtfulness it demands. To reign in factory farms, empower family farmers, and make healthy food more readily available and affordable. We can and must do all of that. But RFK Jr. is not the man to do it.
    The medical profession, at it’s best, is about helping people. I think about doctors like my dad, Dr. Irv Schatz, aboard a hospital ship – the SS Hope – providing free medical care to people in Latin America. So many like him put their lives and careers on hold to travel far and wide and care for the less fortunate. Helping kids with cleft palates…distributing mosquito nets…delivering babies…treating and preventing diseases. It’s hard and unglamorous and unselfish work.
    And so it takes a special kind of person to do the exact opposite. To do what RFK Jr. did, which is to fly halfway around the world, and cause pain. Cause disease. Cause death. So yes, this is a question of character and competence. But it is also a question of life or death. And who we want in charge, making decisions, when lives are on the line. And it’s our job, here in the Senate, to make damn sure that person isn’t RFK Jr.

    MIL OSI USA News

  • MIL-OSI Australia: Measles alert for Sydney Airport

    Source: New South Wales Health – State Government

    NSW Health is advising people to be alert for signs and symptoms of measles after being notified of a person who was infectious on an international flight into Sydney and a domestic flight to the Gold Coast.
    People who attended the following locations should watch for the development of symptoms:

    Jetstar flight JQ4 from Honolulu arriving at Sydney International Airport at 4:29pm Friday 17 January
    Qantas flight QF596 from Sydney to Gold Coast departed Sydney T3 at 9:03pm Friday 17 January
    Sydney International Airport from 4:30pm – 6:30pm Friday 17 January
    Bus from Sydney International to Sydney Domestic Airport T3 between 5:30pm – 6:30pm Friday 17 January
    Sydney Domestic Airport T3 from 6:30pm – 9:00pm Friday 17 January  

    NSW Health Director of the Communicable Diseases Branch, Dr Christine Selvey said while these locations pose no ongoing risks, people who were on the flights or transiting between the terminals at those times should be on the lookout for symptoms.
    “Symptoms to watch out for include fever, runny nose, sore eyes and a cough, usually followed three or four days later by a red, blotchy rash that spreads from the head and face to the rest of the body,” Dr Selvey said.
    “It can take up to 18 days for symptoms to appear after an exposure, so it’s important for people who visited these locations to look out for symptoms up until Tuesday 4 February. If you experience symptoms, please call ahead before visiting your doctor.
    “We want to remind the community to make sure they are up to date with their vaccinations. The measles vaccine can prevent the disease even after exposure, if given early enough.
    “This should be a reminder for everyone to check that they are protected against measles, which is highly infectious.
    “Anyone born after 1965 needs to ensure they have had two doses of measles vaccine. This is especially important before overseas travel, as measles outbreaks are occurring in several regions of the world at the moment.”
    The measles-mumps-rubella (MMR) vaccine is safe and effective, and is given free for children at 12 and 18 months of age. It is also free in NSW for anyone born after 1965 who hasn’t already had two doses.
    Children under the age of 12 months can have their first dose of MMR up to three months earlier if they are travelling to areas with a high risk for measles. Parents should consult their GP.
    People who are unsure of whether they have had two doses should get a vaccine, as additional doses are safe. This is particularly important prior to travel. MMR vaccine is available from GPs (all ages) and pharmacies (people over 5 years of age).
    For more information on measles, view the measles factsheet .

    MIL OSI News

  • MIL-OSI Australia: City seeks community feedback on Immunisation Services

    Source: State of Victoria Local Government 2

    The City of Greater Bendigo is undertaking a review of its Immunisation Services to ensure the service is meeting the needs of the community.

    Residents can have input into the review by completing a short online survey on the City’s community engagement website Let’s Talk Greater Bendigo by Wednesday December 4, 2024.

    City of Greater Bendigo Acting Manager Community and Environmental Health, Sue Harrison said in the last financial year the City provided a total of 10,504 immunisations at community sessions (6,725), school sessions (3,333) and 446 influenza vaccinations for City staff.

    “The City’s free immunisation services are accessed by a large number of people and by undertaking a review we want to find out residents experiences and satisfaction with the current service,” said Ms Harrison.

    “This is an important project because we want to gain an understanding of the challenges and barriers residents may face when accessing the service and identify what’s working well and the areas where improvements could be made,

    “The information provided by residents through the survey will help us to determine how often, and where, public immunisation clinics are held, if we need to provide better access to the clinics and if services are being delivered in the best possible way.

    “The review is about building community trust and knowledge and we really want to hear the thoughts of residents about the services they use so we can ensure they can access the services they want and need.”

    The survey opens on Wednesday November 6 and will close on Wednesday December 4, 2024.

    MIL OSI News

  • MIL-OSI USA: FDA Roundup: November 5, 2024

    Source: US Department of Health and Human Services – 3

    For Immediate Release:

    Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: 

    • Today, the FDA published “Catching Up with Califf: One Health – Optimal Public Health Outcomes for Humans and Animals in Our Shared Environment,” by FDA Commissioner Robert M. Califf, M.D. Dr. Califf discusses One Health and the FDA’s mission to collaborate across disciplines and sectors to promote the health of humans and animals; and taking into account agricultural and environmental issues, using science, technology, and innovation to better understand and define policies that involve these intersections. The blog also provides details on FDA Center for Veterinary Medicine’s upcoming Symposium: “Paws, Claws, Hooves, Fins, and Feet—Advancements through a One Health Approach.”
    • On Monday, the FDA published the Supplement to the 2022 Food Code. The Supplement updates the 2022 Food Code with recommendations made by regulatory officials, industry, academia, and consumers at the 2023 Biennial Meeting of the Conference for Food Protection. The Food Code and its Supplement provide government and industry with practical, science-based controls for reducing the risk of foodborne illness in retail and foodservice establishments of all types. The Food Code and the Supplement are joint projects by the FDA, the Centers for Disease Control and Prevention, and the United States Department of Agriculture – Food Safety and Inspection Service.
    • On Monday, the FDA, in collaboration with the Environmental Protection Agency (EPA), announced the registration of the first antimicrobial treatment for pathogen reduction in pre-harvest agricultural water—a landmark achievement in enhancing food safety. This product effectively combats foodborne pathogens such as E. coli and Salmonella in water used to grow crops. It is the first label amendment approved under a revised efficacy protocol–designed by the FDA and EPA–to ensure robust treatment options are available for agricultural use. 
    • On Monday, the FDA authorized marketing of LumiThera, Inc.’s Valeda Light Delivery System to help improve vision in certain dry age-related macular degeneration (AMD) patients. According to data on AMD prevalence estimates analyzed by the CDC, in 2019 an estimated 19.8 million Americans aged 40 years and older were living with some type (dry or wet) of AMD.

      “Today’s action brings to market the first therapeutic option for adult patients with dry AMD,” said Malvina Eydelman, M.D., director of the Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices at the FDA’s Center for Devices and Radiological Health. “This authorization reinforces FDA’s commitment to assuring access to innovative, safe and effective medical devices to treat high-prevalence, degenerative conditions.”

      The Valeda Light Delivery System uses three light emitting diodes that generate light at different wavelengths to provide treatment to the patient’s eye. Treatment with the device after approximately two years can provide an average improvement in vision equivalent to around one line on an eye chart. 

    • On Friday, the FDA Office of Criminal Investigations arrested a Massachusetts spa owner, Rebecca Fadanelli, for allegedly performing thousands of illegal injections of counterfeit Botox, Sculptra and Juvederm on clients for over three years. If you or a family member believe you received services involving a counterfeit drug or counterfeit device from Fadanelli and/or Skin Beaute Med Spa in Randolph and South Easton, Mass. between 2021 through and including to the present date, please complete the questionnaire located on the FDA’s website here. 

    Related Information

    ###

    Boilerplate

    The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, radiation-emitting electronic products, and for regulating tobacco products.


    Inquiries

    Consumer:
    888-INFO-FDA

    MIL OSI USA News

  • MIL-OSI: INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. – GLYC

    Source: GlobeNewswire (MIL-OSI)

    NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) — Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating GlycoMimetics, Inc. (NASDAQ: GLYC), relating to a proposed merger with First Crescent Biopharma, Inc. Under the terms of the agreement, the pre-acquisition GlycoMimetics stockholders are expected to own approximately 3.1% of the combined Company and the pre-acquisition Crescent stockholders (inclusive of those investors participating in the pre-closing financing) are expected to own approximately 96.9% of the company.

    Click here for more information https://monteverdelaw.com/case/glycomimetics-inc-glyc/. It is free and there is no cost or obligation to you.

    NOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to a lawyer and ask:

    1. Do you file class actions and go to Court?
    2. When was the last time you recovered money for shareholders?
    3. What cases did you recover money in and how much?

    About Monteverde & Associates PC

    Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. 

    No company, director or officer is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

    Contact:
    Juan Monteverde, Esq.
    MONTEVERDE & ASSOCIATES PC
    The Empire State Building
    350 Fifth Ave. Suite 4740
    New York, NY 10118
    United States of America
    jmonteverde@monteverdelaw.com
    Tel: (212) 971-1341

    Attorney Advertising. (C) 2024 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

    The MIL Network

  • MIL-OSI Global: Friends like these: What a second Trump term may mean for the CDC, and how it affects Canada

    Source: The Conversation – Canada – By Kevin Quigley, Scholarly Director of the MacEachen Institute for Public Policy and Governance, Dalhousie University

    Should Donald Trump be re-elected on Tuesday, the U.S. Centers for Disease Control and Prevention (CDC) is likely facing a major shake-up. Many Republicans were frustrated by the CDC’s performance during the pandemic. Project 2025, authored by leading Republicans with ties to Trump, describes the CDC as incompetent and arrogant.

    In fact, no matter who wins the United States presidential election on Nov. 5, the Trump administration’s response to the COVID-19 pandemic is a cautionary tale for Canada.

    While there is significant and justifiable criticism to be leveled at Trump about his administration’s handling of the pandemic in the early stages, as former chief medical advisor to the president, Dr. Anthony Fauci noted to Congress in 2024, the U.S. health system is not designed for an effective co-ordinated response to a health crisis.

    Trump and the CDC

    There was clearly a disconnect between Trump and the CDC during the pandemic. For weeks in early 2020, President Trump had described the threat as low risk; he said that the situation was under control in the U.S. and that only a few cases had been reported.

    While the president was on a return flight from India, Dr. Nancy Messonnier, director of the National Center for Immunization and Respiratory Diseases at the CDC, announced that the situation in the U.S. was about to change quickly and severely. Officials say that Trump was very upset by the announcement and concerned about potential lockdowns causing panic and disruption to financial markets.

    Throughout the early stages of the pandemic, the actions of the CDC sparked a high degree of politicization. The Trump administration was criticized for interfering with the CDC’s operations and censoring internal experts. Disagreements between federal and state political leaders and public health experts led to inconsistencies in public health messaging, reporting, enforcement of directives and timing of public health restrictions.

    The CDC itself was not above criticism. The agency’s infrastructure had been neglected for decades, and years of declining funding resulted in insufficient preparations for a possible pandemic. The CDC had also been criticized for being too insular and academic.

    The CDC made key mistakes, particularly regarding surveillance and testing. It was criticized for underestimating the threat of the virus and overestimating its ability to design, manufacture and distribute a test quickly.

    Rapid responses are crucial during such events, and the early stages of the U.S.’s pandemic response provides salient lessons for Canada, both about its relationship with the U.S. and to global threats more generally.

    Pre-event planning is necessary, but audits and world rankings of emergency preparedness can be unreliable. In 2019, Johns Hopkins University ranked the U.S. as the best prepared country in the world to address a health crisis. The pandemic demonstrated that it was not.

    Canada needs to establish a strong and independent capacity to assess health threats. Trump’s early handling of the pandemic has been widely criticized, yet the Canadian government’s speaking points in the early stages were the same: the virus was low risk. It was only when the CDC and the World Health Organization increased its threat assessment that Canada followed suit.

    Lessons from the pandemic

    Borders can re-assert themselves. Despite decades of global political and economic agreements that saw a freer flow of goods, services and people, many western governments were unable or unwilling to assume the risks associated with letting those from other jurisdictions cross their borders, and as such, imposed strict rules to prevent non-citizens from entering. This aggressive stance was ironic and unforeseen, as during previous public health crises such as the H1N1 flu episode in 2009-10, many governments underscored that closing borders had little impact on disease spread.

    The weaknesses of supply chains were highlighted as the global economy shut down in March 2020. Canada’s Minister of Finance Chrystia Freeland described competition for medical supplies and personal protective equipment (PPE) as resembling the “wild west.” Shipment delays, order shortages, trade restrictions and defective or contaminated items prevented governments from effectively procuring supplies.

    Global manufacturing capabilities for vaccines were below what was needed, with only about a dozen countries able to produce COVID-19 vaccines early on, including the U.S. More than any other country, the U.S. enabled the rapid development and production of the vaccine, highlighting Canada’s considerable dependence on the U.S. Canada has since funded vaccine manufacturing initiatives, but the investments have produced little to-date.

    The adage “When the U.S. sneezes, the world catches a cold” applies nowhere more than in Canada. Should Trump be re-elected, the CDC will likely exist on a smaller budget with a reduced role internationally. This will increase Canadian vulnerabilities.

    Whatever the criticisms, the CDC has more capacity and influence than any other health agency in the world. If Canada cannot depend on strong and co-ordinated response from the U.S. administration during a health crisis, Canada has to be better prepared to adapt. Lessons from the pandemic provide a powerful to-do list.

    Kevin Quigley is the Scholarly Director of the MacEachen Institute for Public Policy and Governance, an independent, non-partisan research institute located at Dalhousie University.

    ref. Friends like these: What a second Trump term may mean for the CDC, and how it affects Canada – https://theconversation.com/friends-like-these-what-a-second-trump-term-may-mean-for-the-cdc-and-how-it-affects-canada-242673

    MIL OSI – Global Reports

  • MIL-OSI Economics: African Development Bank-backed research highlights potential of health tech to boost Africa’s health systems

    Source: African Development Bank Group

    A new study co-funded by the African Development Bank finds that applying technology to healthcare delivery, management, and research could provide more Africans with universal health coverage and significantly advance Africa’s progress towards achieving the United Nations Sustainable Development Goals.

    The report, titled Policy Blueprint to Fast-Track Healthtech Innovations in Public Health in Africa, examined the potential of health technology innovations – called healthtech to benefit patients, health systems and communities across the continent. Commissioned by HealthTech Hub Africa and produced by VillageReach, the study was funded by UBS Optimus Foundation and the African Development Bank Group’s Innovation and Entrepreneurship Lab with financing from the Swiss State Secretariat for Economic Affairs.

    The study, conducted between May 2023 and February 2024, involved data collection and stakeholder consultation with innovators, startups, investors, civil society, and government and civil society representatives across 11 African countries — Côte d’Ivoire, Ethiopia, Kenya, Malawi, Nigeria, Rwanda, Senegal, South Africa, Tanzania, Uganda, and Cameroon.

    The findings offer policy guidance, specific actions and practical examples to accelerate healthtech in Africa while supporting innovation development, testing and sustainability.

    Dr. Babatunde Omilola, the African Development Bank’s Manager for Public Health, Security and Social Protection, emphasized the timeliness of the report. “This policy blueprint comes at a very opportune time as it gives policy directions to governments across Africa who are witnessing increased entrepreneurs involved in developing innovative healthtech products. The policy guidance will help create an enabling environment for products that can improve healthcare access and quality while reducing costs for millions.”

    The report identified several challenges hindering mainstreaming health tech in Africa, including:

    • Lack of unified, comprehensive and updated policies
    • Complex licensing processes
    • Fragmented and poorly digitized health data systems
    • Insufficient funding and innovation incentives

    To address these issues, the report recommends:

    • Strengthening dialogue and coordination among healthtech stakeholders
    • Refining policies on health data access and interoperability
    • Accelerating innovation while safeguarding data

    The study aligns with the African Development Bank’s broader efforts to improve healthcare across the continent. In 2022, the Bank approved its Strategy for Quality Health Infrastructure for Africa 2022-2030, which supports facilities like connection to water and sanitation, energy, transport, and communications services. In 2020, it adopted the Pharmaceutical Sector Action Plan to enhance local production capacities of medicines and vaccines and support research and development of pharmaceutical products.

    Click here to read the report.

    MIL OSI Economics

  • MIL-Evening Report: Primary care involves more than GPs. A new review shows how patients can better access care

    Source: The Conversation (Au and NZ) – By Stephen Duckett, Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne

    Drazen Zigic/Shutterstock

    Australians today are more likely than previous generations to live with complex and chronic diseases, such as diabetes, heart disease and depression.

    This means they’re more likely to need health care from a variety of different providers, such as nurses, podiatrists, psychologists and physiotherapists, as well as GPs. This is known as “multidisciplinary care”. It works best when the skills of all these professions are available to the patient in a co-ordinated way.

    But the roles of health professions, and the way they’re funded, have been frozen in legislation and policy for decades. Any change has been incremental and disjointed. It has mostly involved adding more items to the Medicare schedule, with each professional practising separately.

    The result has been greater inequity of access. Because fewer than half of allied health fee-for-service visits are bulk-billed, most patients pay almost A$70 for each consultation – and sometimes much more. Those who can’t afford the out-of-pocket costs and can’t find a bulk-billing practitioner miss out.

    To assess how the government can remove barriers to team-based care and get health professions working to their full potential, or their full “scope of practice”, last year the government commissioned an independent review.

    The final report, released yesterday, sets a new path for the primary care workforce. This could make multidisciplinary care within reach of all Australians.

    Using health-care workers’ full potential

    The review involved extensive consultation, including on two issues papers. The report itself incorporates feedback from the consultations, including sceptical comments, reflecting a divergence of opinions.

    Reflected the report’s title, Unleashing the Potential of our Health Workforce, its main emphasis is to change the rules and regulations imposed by state and federal governments. These stymie health professionals and limit their ability to use their full skills and knowledge to manage their patients’ care.

    Over recent decades, health professionals’ education has improved. So professionals are capable of doing more than previously. Yet the rules and regulations have not advanced and so inhibit professionals from making those skills and knowledge available.

    The review argues this contributes to career dissatisfaction, and to people leaving various health professions, exacerbating workforce shortages.

    The review proposes a new way of documenting and describing what can be done by a profession through what it calls a National Skills and Capability Framework and Matrix.

    As with many other recommendations, the review points to where this is done already internationally and how it can nestle into other policies and frameworks to aid implementation.

    Health-care workers aren’t using all their skills.
    DC studio/Shutterstock

    To the disappointment of most allied health professions, the review does not recommend more Medicare payments for them to practise independently.

    Rather, the review recommends payment to general practices for them to expand multi-disciplinary teams. This would see professionals working together, rather than in competition or isolation.

    The review also recommends changing the rules about referrals by health professionals, allowing qualified health professionals to refer directly to non-GP medical specialists in similar areas. This means your psychologist could refer you directly to a psychiatrist if needed, or your physiotherapist could refer you directly to an orthopaedic surgeon rather than needing to go back to your GP.

    This will weaken the role of the GP as a “gatekeeper” and also potentially undermine the more holistic care that GPs provide. But from a patient’s point of view, eliminating the intermediate step saves them out-of-pocket costs.

    An important recommendation recognises that the health system evolves and rules and regulations need to evolve too. It therefore supplements its recommendations for changes now, with an approach for continuous review through an independent mechanism. This would provide evidence-based advice and recommendations about:

    • significant workforce innovation
    • emerging health care roles
    • workforce models that involve significant change to scope.

    When will we see change?

    The review sets out a loose timeline for implementation, described as short, medium and long term. And it assigns responsibility for each element of its recommendations to appropriate bodies and governments.

    As almost all the recommendations require legislative change, and many require agreement between the Commonwealth and the states, it’s unlikely any of the changes will take effect this financial year.

    The review recommends change be implemented in a systematic, evidence-based and safe way. Implementation would start in areas of greatest need such as in rural and remote Australia and also in practices most ready for the change, such as Aboriginal Controlled Community Health Organisations or Victoria’s Community Health Centres.

    The review recommends changes to the referral process.
    voronaman/Shutterstock

    In releasing what he referred to as a “landmark” report, Health Minister Mark Butler noted the complexity of implementation, which would require collaborative action with states and territories. He noted the need for further consultation, but nevertheless took a supportive tone.

    Can this review prompt real health reform?

    Overall, the review charts a middle course between letting health professionals roam free and the tight and inappropriate rules and regulations which constrain patient care today. It also sets out the practical steps to achieve its goals.

    The one downside of the report is the emphasis on harmonisation of state and territory approaches. This would replace the current approach, where each state and territory decides, for example, on what vaccines can be administered by which professionals and what pharmacists can dispense without a medical practitioner’s prescription.

    One of the benefits of a federation is the potential for state- and territory-based innovation and cross-border learning. Harmonisation will limit that experimenting, and may lead to more of the stasis seen in health workforce policy in the past.

    Stephen Duckett was consulted by the Independent Reviewer during the course of the Review and commented on the Review’s Issues Papers and Draft Final Report

    ref. Primary care involves more than GPs. A new review shows how patients can better access care – https://theconversation.com/primary-care-involves-more-than-gps-a-new-review-shows-how-patients-can-better-access-care-242698

    MIL OSI AnalysisEveningReport.nz

  • MIL-OSI United Kingdom: UK to create world-first ‘early warning system’ for pandemics

    Source: United Kingdom – Executive Government & Departments

    The government is set to partner with Oxford Nanopore, which uses technology to rapidly diagnose a range of cancers, along with rare and infectious diseases

    • New partnership with cutting-edge life sciences company Oxford Nanopore will lead to better scientific research and could create tests and treatments for patients, saving lives

    • Patients suspected of having severe acute respiratory infections will be diagnosed within 6 hours, supporting the establishment of a new diagnostic system

    • Technology will allow potential outbreaks of bacterial or viral diseases to be monitored alongside antimicrobial resistance, shifting NHS from analogue to digital as part of 10-Year Health Plan

    The UK will create the world’s first real-time surveillance system to monitor the threat of future pandemics, prevent disease, and protect the public.

    Plans have been announced to form a new partnership between the government, Genomics England, UK Biobank, NHS England, and Oxford Nanopore – a UK-headquartered, world-leading life sciences company. 

    Oxford Nanopore uses long read sequencing technology to analyse genes and pathogens to rapidly diagnose a range of cancers, along with rare and infectious diseases. The technology can sequence long strands of DNA or RNA in one go, without breaking it up into smaller fragments.

    In infectious diseases, Oxford Nanopore’s technology will help to create an early warning system for future pandemics and potential biological threats, both preventing disease and protecting the public.

    It will be used in the expansion of NHS England’s Respiratory Metagenomics programme, being led by Guy’s and St Thomas’ NHS Foundation Trust (GSTT). It uses samples from patients with severe respiratory infections and rapid genetic testing to match those patients with the right treatments within 6 hours.

    This novel and world-leading application, developed in partnership with the NHS, will allow potential outbreaks of bacterial or viral diseases to be monitored alongside antimicrobial resistance across the country. 

    Following an initial successful pilot at St Thomas’ Hospital, the technology will now be rolled out from 10 to up to 30 NHS sites to address the current time lag between new pathogens emerging in the UK and action being taken to both treat affected patients and to prevent their spread, which will benefit people everywhere.

    Health and Social Care Secretary Wes Streeting said:

    If we fail to prepare, we should prepare to fail. Our NHS was already on its knees when the pandemic struck, and it was hit harder than any other comparable healthcare system.

    We cannot let history repeat itself. That’s why this historic partnership with Oxford Nanopore will ensure our world-leading scientists have the latest information on emerging threats at their fingertips.

    As we embrace the technological revolution, our 10-Year Health Plan will shift the NHS away from analogue to digital, saving countless more lives.

    Science and Technology Secretary Peter Kyle said:

    During the Covid pandemic, we saw the power of the UK life sciences sector very clearly, from the Oxford-Astra Zeneca vaccine that saved so many lives, through to operating one of the world’s most effective Covid surveillance systems, which spotted several emerging variants of the disease.

    This partnership will build on that expertise to monitor emerging diseases as they arise, putting our scientists and decision-makers one-step ahead and providing the information they need to make informed decisions.

    Together with the ability to better diagnose cancers and rare diseases, we are leveraging UK life sciences to protect the public and ultimately save lives.

    Professor Susan Hopkins, Chief Medical Advisor at UK Health Security Agency, said:

    Early detection is absolutely crucial in enabling us to respond effectively to any emerging pathogen. The UK already has a wealth of expertise in genomic surveillance, and this programme will build on that expertise and enable us to bring our resources and capability to tackle developing threats at greater speed. Enhancing the capacity for the NHS to determine new and emerging pathogens causing severe acute respiratory infections will improve the detection and emergence of infections.

    As part of the 100 days mission, this will enable the development of effective diagnostics for novel pathogens and enhance our pandemic preparedness.

    Oxford Nanopore CEO Gordon Sanghera said:

    The UK has a remarkable life science ecosystem, and we are delighted to be working more closely with the UK government and the NHS in this collaboration.

    The world-renowned Genomics England and UK Biobank have led the way in scaling genomics discovery and translating these advances into patient impact.

    By working alongside our partners on shared goals of improved patient outcomes – whether in cancer, genetic disease or infectious disease – and pandemic preparedness, we believe we can deploy our unique DNA sequencing technology in ways that are most impactful for the people of the UK.

    Professor Ian Abbs, chief executive of Guy’s and St Thomas’ NHS Foundation Trust, said:

    We’ve been working on the respiratory metagenomics programme for over 4 years and have clearly seen the benefit to our patients. It’s a momentous day now that we can ensure other hospitals, and more patients, can also benefit from faster and more accurate treatment for severe respiratory conditions thanks to new genomic technology.

    As part of the expansion to the metagenomics programme, the data gathered using Oxford Nanopore’s technology will be provided to the UK Health and Security Agency, allowing quicker detection and action on emerging infectious diseases to be taken.

    The collaboration between the government and Oxford Nanopore – which will also join up Genomics England and UK Biobank with NHS England – is another key vote of confidence in the UK’s life sciences sector, which will help kickstart economic growth and support the 10-Year Health Plan’s ambition to shift the health service from analogue to digital and from sickness to prevention, helping keep patients out of hospital. 

    Genomics England will work strategically with Oxford Nanopore to further insights from the data they hold, including on cancer and rare diseases, to enable future breakthroughs in identifying genomic mutations that may be treatable and preventing these devastating conditions. UK Biobank will also continue to work with Oxford Nanopore and the government to improve the insights from their data and translate these into impact for NHS patients.

    Along with the vast benefits to patients, this work will drive economic growth, supporting the expansion of one of our most promising life sciences companies. 

    This partnership comes hot on the heels of the Budget, where the government announced investment of £40m over 5 years in a Proof of Concept Fund for spinouts, companies formed based on academic research generated within and owned by a university. 

    This will build on the excellent example set by Oxford Nanopore, one of the UK’s most successful spinout companies, having been founded at Oxford University in 2005. This fund could help to unleash a raft of innovative new spinouts like Oxford Nanopore, helping to drive job creation and economic growth.

    Updates to this page

    Published 5 November 2024

    MIL OSI United Kingdom

  • MIL-OSI Asia-Pac: President Lai meets Czech national baseball team  

    Source: Republic of China Taiwan

    President Lai meets Czech national baseball team  
    2024-11-01

    On the afternoon of November 1, President Lai Ching-te met with the national baseball team of the Czech Republic. In remarks, President Lai thanked the Czech Republic for supporting Taiwan, and noted that the Czech national baseball team had come to Taiwan to take part in two exhibition games, not only for the sake of learning from one another, but also to further cultivate friendship between Taiwan and the Czech Republic. He also stated that the Czech Republic is an important democratic ally of Taiwan in Europe. He stated that the opening of the Czech Centre Taipei this past June shows that our two countries continue to enhance our partnership, and expressed confidence that even greater advances will be achieved in culture and many other fields moving forward.
    A translation of President Lai’s remarks follows:
    The World Baseball Softball Confederation Premier12 tournament is scheduled to start on November 10, with Group B opening round games to be played in Taiwan. I would like to thank Chinese Professional Baseball League Commissioner Tsai Chi-chang (蔡其昌) for inviting the Czech national baseball team to play two exhibition games in Taiwan, not only for the sake of learning from one another, but also to further cultivate friendship between Taiwan and the Czech Republic.
    As a long-time baseball fan, I am very pleased to meet with the Czech national baseball team here at the Presidential Office. Many team members are actually part-timers whose principal occupations are in such fields as firefighting, teaching, medicine, financial analysis, and real estate brokerage, to name just a few. Everyone’s passion for the sport has earned the team a ranking of number 15 in the world and placed them among the top three in Europe. Indeed, in last year’s World Baseball Classic (WBC), the team scored a come-from-behind win over China to take the Czech Republic’s first-ever victory in the WBC tournament. It was an admirable win and an exciting game, and Taiwanese fans were thrilled.
    The Czech Republic is an important democratic ally of Taiwan in Europe. Representative of the Czech Economic and Cultural Office David Steinke is here, so I would like to give special thanks to the Czech Republic for supporting Taiwan. Three years ago, in the midst of the COVID-19 pandemic, the Czech Republic generously donated 30,000 vaccine doses to Taiwan, and when Hualien was hit by a severe earthquake earlier this year, the Czech Republic donated US$150,000 to support reconstruction efforts. On behalf of the people of Taiwan, I want to express our deepest appreciation.
    The opening of the Czech Centre Taipei this past June signifies that our two countries continue to enhance our partnership, and I am confident that even greater advances will be achieved in culture and many other fields moving forward.
    Today is the Czech national baseball team’s second day in Taiwan, so I want to wish everyone a happy and fruitful visit, and I look forward to both teams playing their best in the exhibition games scheduled for tomorrow and the day after.
    Also in attendance was Czech Baseball Association President Petr Ditrich.

    MIL OSI Asia Pacific News

  • MIL-OSI United Kingdom: More pop up clinics arranged for winter vaccinations

    Source: City of Wolverhampton

    Similar to last year, those eligible for a free Covid-19 and flu vaccination include all adults aged 65 years and over, people who live in a care home for older adults, people aged 6 months to 64 years with health conditions that make them more vulnerable, frontline health and social care staff including those working in care homes for older adults, and pregnant women.

    Eligible people can get one or both vaccinations and are invited to book an appointment via the NHS website, on the NHS app or by calling 119.

    Alternatively, they can get their vaccinations at one of a number of community pop up clinics offering both vaccines without an appointment which are taking place across the city over the coming weeks, including:

    • Phoenix Park, Dudley Road, today (Monday 4 November) and Monday 18 November from 9am to 3pm
    • SMI Steps to Health, Showell Circus, tomorrow (Tuesday 5 November) from 9am to 3pm
    • Sainsburys Wolverhampton, Raglan Street, on Thursday (7 November) and Thursday 21 November from 9am to 3pm
    • Queen Square, Wolverhampton, on Friday (8 November) and Friday 22 November from 9am to 3pm
    • Sainsburys Wednesfield, Bentley Bridge, on Thursdays 14 and 28 November from 11am to 6pm.

    Anyone not eligible for a free flu vaccination is reminded that they can get it for a small charge at participating pharmacists.

    Sally Roberts, Chief Nursing Officer for the NHS Black Country Integrated Care Board, said: “It’s vital that everyone prepares for potential winter illnesses, especially those who are at higher risk.

    “It can be easy to become complacent, however it’s important for those who are eligible to top up their protection, even if they have had a vaccine or been ill with flu or Covid-19 before, as immunity fades over time and these viruses change each year.”

    Councillor Jasbir Jaspal, the City of Wolverhampton Council’s Cabinet Member for Adults and Wellbeing, said: “Getting vaccinated will help you get winter strong so, I would encourage anyone who is eligible to take up the offer of a free flu or Covid-19 vaccination, or both.”

    MIL OSI United Kingdom